EP2344117A2 - Utilisation d'hydrophobine dans la coloration non permanente de la kératine - Google Patents
Utilisation d'hydrophobine dans la coloration non permanente de la kératineInfo
- Publication number
- EP2344117A2 EP2344117A2 EP09781840A EP09781840A EP2344117A2 EP 2344117 A2 EP2344117 A2 EP 2344117A2 EP 09781840 A EP09781840 A EP 09781840A EP 09781840 A EP09781840 A EP 09781840A EP 2344117 A2 EP2344117 A2 EP 2344117A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- hydrophobin
- keratin
- permanent
- hair
- dye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 101710091977 Hydrophobin Proteins 0.000 title claims abstract description 148
- 102000011782 Keratins Human genes 0.000 title claims abstract description 113
- 108010076876 Keratins Proteins 0.000 title claims abstract description 113
- 238000004043 dyeing Methods 0.000 title claims abstract description 32
- 210000004209 hair Anatomy 0.000 claims abstract description 113
- 238000000034 method Methods 0.000 claims abstract description 51
- 239000000463 material Substances 0.000 claims abstract description 33
- 239000000975 dye Substances 0.000 claims description 114
- 239000000203 mixture Substances 0.000 claims description 88
- 230000004927 fusion Effects 0.000 claims description 28
- 239000002537 cosmetic Substances 0.000 claims description 25
- 238000010186 staining Methods 0.000 claims description 24
- 230000000694 effects Effects 0.000 claims description 21
- 239000004480 active ingredient Substances 0.000 claims description 17
- 238000004040 coloring Methods 0.000 claims description 10
- 239000000118 hair dye Substances 0.000 claims description 8
- 101100387133 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) dewA gene Proteins 0.000 claims description 7
- 101100215658 Aspergillus parasiticus (strain ATCC 56775 / NRRL 5862 / SRRC 143 / SU-1) aflY gene Proteins 0.000 claims description 4
- 101100232322 Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110) hypA2 gene Proteins 0.000 claims description 4
- 101100059802 Chlamydophila caviae (strain ATCC VR-813 / DSM 19441 / GPIC) groEL1 gene Proteins 0.000 claims description 4
- 101100365080 Clostridium perfringens (strain 13 / Type A) scpB gene Proteins 0.000 claims description 4
- 101100232321 Synechocystis sp. (strain PCC 6803 / Kazusa) hypA1 gene Proteins 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 101150077981 groEL gene Proteins 0.000 claims description 4
- 101150006844 groES gene Proteins 0.000 claims description 4
- 230000037308 hair color Effects 0.000 claims description 4
- 101150081485 hypA gene Proteins 0.000 claims description 4
- 101150019385 hypB gene Proteins 0.000 claims description 4
- 239000013543 active substance Substances 0.000 claims description 2
- 108020001507 fusion proteins Proteins 0.000 claims description 2
- 102000037865 fusion proteins Human genes 0.000 claims description 2
- 101150001852 mrdB gene Proteins 0.000 claims description 2
- 101150042737 rodA gene Proteins 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 description 41
- 150000001413 amino acids Chemical class 0.000 description 40
- 102000004169 proteins and genes Human genes 0.000 description 39
- 235000001014 amino acid Nutrition 0.000 description 38
- 239000003086 colorant Substances 0.000 description 38
- 235000018102 proteins Nutrition 0.000 description 38
- 229940024606 amino acid Drugs 0.000 description 35
- 108090000765 processed proteins & peptides Proteins 0.000 description 26
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 21
- 102000004196 processed proteins & peptides Human genes 0.000 description 20
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 19
- 229920001184 polypeptide Polymers 0.000 description 17
- 229940088594 vitamin Drugs 0.000 description 17
- 229930003231 vitamin Natural products 0.000 description 17
- 235000013343 vitamin Nutrition 0.000 description 17
- 239000011782 vitamin Substances 0.000 description 17
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 16
- 239000000126 substance Substances 0.000 description 16
- -1 Fatty acid alcohols Chemical class 0.000 description 15
- 239000001024 permanent hair color Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 239000000306 component Substances 0.000 description 14
- 239000012636 effector Substances 0.000 description 14
- 229920001213 Polysorbate 20 Polymers 0.000 description 13
- 235000018417 cysteine Nutrition 0.000 description 13
- 239000002953 phosphate buffered saline Substances 0.000 description 13
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 13
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000003963 antioxidant agent Substances 0.000 description 12
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 12
- 230000008569 process Effects 0.000 description 12
- 238000005406 washing Methods 0.000 description 12
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 11
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 11
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 11
- 235000006708 antioxidants Nutrition 0.000 description 11
- 239000000982 direct dye Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 10
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 10
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 10
- 102000003992 Peroxidases Human genes 0.000 description 10
- 238000005259 measurement Methods 0.000 description 10
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 10
- 235000020957 pantothenol Nutrition 0.000 description 10
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 229910021529 ammonia Inorganic materials 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 229940101267 panthenol Drugs 0.000 description 9
- 239000011619 pantothenol Substances 0.000 description 9
- 108040007629 peroxidase activity proteins Proteins 0.000 description 9
- 239000001026 semi permanent hair color Substances 0.000 description 9
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 8
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 8
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 7
- 101710195795 Hydrophobin-B Proteins 0.000 description 7
- 150000001945 cysteines Chemical class 0.000 description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 229960002477 riboflavin Drugs 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 239000002453 shampoo Substances 0.000 description 7
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 6
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 6
- 238000010353 genetic engineering Methods 0.000 description 6
- 230000002209 hydrophobic effect Effects 0.000 description 6
- 229960003512 nicotinic acid Drugs 0.000 description 6
- 239000002243 precursor Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 101710195603 Hydrophobin A Proteins 0.000 description 5
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 5
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 5
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 5
- 239000004904 UV filter Substances 0.000 description 5
- 229930003427 Vitamin E Natural products 0.000 description 5
- 235000004279 alanine Nutrition 0.000 description 5
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 5
- 235000010323 ascorbic acid Nutrition 0.000 description 5
- 239000011668 ascorbic acid Substances 0.000 description 5
- 229960005070 ascorbic acid Drugs 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 125000002091 cationic group Chemical group 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000003776 cleavage reaction Methods 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 210000003000 inclusion body Anatomy 0.000 description 5
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 229930182817 methionine Natural products 0.000 description 5
- 235000005152 nicotinamide Nutrition 0.000 description 5
- 239000011570 nicotinamide Substances 0.000 description 5
- SERHXTVXHNVDKA-UHFFFAOYSA-N pantolactone Chemical compound CC1(C)COC(=O)C1O SERHXTVXHNVDKA-UHFFFAOYSA-N 0.000 description 5
- 229940055726 pantothenic acid Drugs 0.000 description 5
- 235000019161 pantothenic acid Nutrition 0.000 description 5
- 239000011713 pantothenic acid Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 229930002330 retinoic acid Natural products 0.000 description 5
- 230000007017 scission Effects 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 239000001027 temporary hair color Substances 0.000 description 5
- 229930003799 tocopherol Natural products 0.000 description 5
- 239000011732 tocopherol Substances 0.000 description 5
- 235000019165 vitamin E Nutrition 0.000 description 5
- 239000011709 vitamin E Substances 0.000 description 5
- 229940046009 vitamin E Drugs 0.000 description 5
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 5
- WHVNXSBKJGAXKU-UHFFFAOYSA-N Alexa Fluor 532 Chemical compound [H+].[H+].CC1(C)C(C)NC(C(=C2OC3=C(C=4C(C(C(C)N=4)(C)C)=CC3=3)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=C2C=3C(C=C1)=CC=C1C(=O)ON1C(=O)CCC1=O WHVNXSBKJGAXKU-UHFFFAOYSA-N 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- MIWUTEVJIISHCP-UHFFFAOYSA-N HC Blue No. 2 Chemical compound OCCNC1=CC=C(N(CCO)CCO)C=C1[N+]([O-])=O MIWUTEVJIISHCP-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 4
- 239000006180 TBST buffer Substances 0.000 description 4
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 4
- 239000004473 Threonine Substances 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- RFQSMLBZXQOMKK-UHFFFAOYSA-N [3-[(4,8-diamino-6-bromo-1,5-dioxonaphthalen-2-yl)amino]phenyl]-trimethylazanium;chloride Chemical compound [Cl-].C[N+](C)(C)C1=CC=CC(NC=2C(C3=C(N)C=C(Br)C(=O)C3=C(N)C=2)=O)=C1 RFQSMLBZXQOMKK-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 4
- 235000021466 carotenoid Nutrition 0.000 description 4
- 150000001747 carotenoids Chemical class 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 229930003935 flavonoid Natural products 0.000 description 4
- 235000017173 flavonoids Nutrition 0.000 description 4
- 150000002215 flavonoids Chemical class 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000002538 fungal effect Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- IPSIPYMEZZPCPY-UHFFFAOYSA-N new fuchsin Chemical compound [Cl-].C1=CC(=[NH2+])C(C)=CC1=C(C=1C=C(C)C(N)=CC=1)C1=CC=C(N)C(C)=C1 IPSIPYMEZZPCPY-UHFFFAOYSA-N 0.000 description 4
- 235000001968 nicotinic acid Nutrition 0.000 description 4
- 239000011664 nicotinic acid Substances 0.000 description 4
- 150000007523 nucleic acids Chemical group 0.000 description 4
- 230000001590 oxidative effect Effects 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- 229960003471 retinol Drugs 0.000 description 4
- 235000020944 retinol Nutrition 0.000 description 4
- 239000011607 retinol Substances 0.000 description 4
- 235000019192 riboflavin Nutrition 0.000 description 4
- 239000002151 riboflavin Substances 0.000 description 4
- 235000004400 serine Nutrition 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- 229960003495 thiamine Drugs 0.000 description 4
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 229940045997 vitamin a Drugs 0.000 description 4
- 229940011671 vitamin b6 Drugs 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- SCZQUWZLEIYDBD-UHFFFAOYSA-N 2-(4-methyl-2-nitroanilino)ethanol Chemical compound CC1=CC=C(NCCO)C([N+]([O-])=O)=C1 SCZQUWZLEIYDBD-UHFFFAOYSA-N 0.000 description 3
- NJZCRXQWPNNJNB-UHFFFAOYSA-N 2-[2-nitro-4-(trifluoromethyl)anilino]ethanol Chemical compound OCCNC1=CC=C(C(F)(F)F)C=C1[N+]([O-])=O NJZCRXQWPNNJNB-UHFFFAOYSA-N 0.000 description 3
- VTXBLQLZQLHDIL-UHFFFAOYSA-N 4-(3-hydroxypropylamino)-3-nitrophenol Chemical compound OCCCNC1=CC=C(O)C=C1[N+]([O-])=O VTXBLQLZQLHDIL-UHFFFAOYSA-N 0.000 description 3
- NZDXSXLYLMHYJA-UHFFFAOYSA-M 4-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]-n,n-dimethylaniline;chloride Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1N=NC1=[N+](C)C=CN1C NZDXSXLYLMHYJA-UHFFFAOYSA-M 0.000 description 3
- IQXUIDYRTHQTET-UHFFFAOYSA-N 4-amino-3-nitrophenol Chemical compound NC1=CC=C(O)C=C1[N+]([O-])=O IQXUIDYRTHQTET-UHFFFAOYSA-N 0.000 description 3
- TWLMSPNQBKSXOP-UHFFFAOYSA-N 6358-09-4 Chemical compound NC1=CC([N+]([O-])=O)=CC(Cl)=C1O TWLMSPNQBKSXOP-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- GZGZVOLBULPDFD-UHFFFAOYSA-N HC Red No. 3 Chemical compound NC1=CC=C(NCCO)C([N+]([O-])=O)=C1 GZGZVOLBULPDFD-UHFFFAOYSA-N 0.000 description 3
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 244000208060 Lawsonia inermis Species 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- NCYCYZXNIZJOKI-OVSJKPMPSA-N Retinaldehyde Chemical compound O=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 3
- 241000222481 Schizophyllum commune Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229930003471 Vitamin B2 Natural products 0.000 description 3
- 229930003756 Vitamin B7 Natural products 0.000 description 3
- HSWXSHNPRUMJKI-UHFFFAOYSA-N [8-[(2-methoxyphenyl)hydrazinylidene]-7-oxonaphthalen-2-yl]-trimethylazanium;chloride Chemical compound [Cl-].COC1=CC=CC=C1N\N=C/1C2=CC([N+](C)(C)C)=CC=C2C=CC\1=O HSWXSHNPRUMJKI-UHFFFAOYSA-N 0.000 description 3
- CMPPYVDBIJWGCB-UHFFFAOYSA-N [8-[(4-amino-3-nitrophenyl)hydrazinylidene]-7-oxonaphthalen-2-yl]-trimethylazanium;chloride Chemical compound [Cl-].C12=CC([N+](C)(C)C)=CC=C2C=CC(=O)\C1=N\NC1=CC=C(N)C([N+]([O-])=O)=C1 CMPPYVDBIJWGCB-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 3
- 235000013734 beta-carotene Nutrition 0.000 description 3
- 239000011648 beta-carotene Substances 0.000 description 3
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 3
- 229960002747 betacarotene Drugs 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 229960001948 caffeine Drugs 0.000 description 3
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 3
- 235000013877 carbamide Nutrition 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 235000010389 delta-tocopherol Nutrition 0.000 description 3
- 235000010386 dodecyl gallate Nutrition 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 239000008176 lyophilized powder Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- AFAJYBYVKUTWJK-UHFFFAOYSA-N n'-(5-methoxy-2-nitrophenyl)ethane-1,2-diamine;hydrochloride Chemical compound Cl.COC1=CC=C([N+]([O-])=O)C(NCCN)=C1 AFAJYBYVKUTWJK-UHFFFAOYSA-N 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 150000003013 phosphoric acid derivatives Chemical group 0.000 description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 3
- 235000020945 retinal Nutrition 0.000 description 3
- 239000011604 retinal Substances 0.000 description 3
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 235000019149 tocopherols Nutrition 0.000 description 3
- 229960001727 tretinoin Drugs 0.000 description 3
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 3
- 235000019164 vitamin B2 Nutrition 0.000 description 3
- 239000011716 vitamin B2 Substances 0.000 description 3
- 235000019158 vitamin B6 Nutrition 0.000 description 3
- 239000011726 vitamin B6 Substances 0.000 description 3
- 235000011912 vitamin B7 Nutrition 0.000 description 3
- 239000011735 vitamin B7 Substances 0.000 description 3
- 210000002268 wool Anatomy 0.000 description 3
- 238000010626 work up procedure Methods 0.000 description 3
- 235000004835 α-tocopherol Nutrition 0.000 description 3
- 239000002076 α-tocopherol Substances 0.000 description 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 3
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 3
- 239000002446 δ-tocopherol Substances 0.000 description 3
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 2
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 description 2
- LFOUYKNCQNVIGI-UHFFFAOYSA-N 2-(2-nitroanilino)ethanol Chemical compound OCCNC1=CC=CC=C1[N+]([O-])=O LFOUYKNCQNVIGI-UHFFFAOYSA-N 0.000 description 2
- LXKQJEXWFGAMMW-UHFFFAOYSA-N 2-[4-[ethyl(2-hydroxyethyl)amino]-2-nitroanilino]ethanol;hydrochloride Chemical compound Cl.OCCN(CC)C1=CC=C(NCCO)C([N+]([O-])=O)=C1 LXKQJEXWFGAMMW-UHFFFAOYSA-N 0.000 description 2
- ASAQRGCLIPUSEK-UHFFFAOYSA-N 2-[4-amino-n-(2-hydroxyethyl)-3-nitroanilino]ethanol;hydrochloride Chemical compound Cl.NC1=CC=C(N(CCO)CCO)C=C1[N+]([O-])=O ASAQRGCLIPUSEK-UHFFFAOYSA-N 0.000 description 2
- GTMWPZKEYRLDJV-UHFFFAOYSA-N 2-[n-(2-hydroxyethyl)-4-(2-methoxyethylamino)-3-nitroanilino]ethanol;hydrochloride Chemical compound Cl.COCCNC1=CC=C(N(CCO)CCO)C=C1[N+]([O-])=O GTMWPZKEYRLDJV-UHFFFAOYSA-N 0.000 description 2
- WHJNKCNHEVCICH-UHFFFAOYSA-N 2-nitro-1-n-phenylbenzene-1,4-diamine Chemical compound [O-][N+](=O)C1=CC(N)=CC=C1NC1=CC=CC=C1 WHJNKCNHEVCICH-UHFFFAOYSA-N 0.000 description 2
- OTXNTMVVOOBZCV-UHFFFAOYSA-N 2R-gamma-tocotrienol Natural products OC1=C(C)C(C)=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 OTXNTMVVOOBZCV-UHFFFAOYSA-N 0.000 description 2
- YFKNIPGAJBJZQT-UHFFFAOYSA-N 3-(4-amino-2-chloro-5-nitroanilino)propane-1,2-diol Chemical compound NC1=CC(Cl)=C(NCC(O)CO)C=C1[N+]([O-])=O YFKNIPGAJBJZQT-UHFFFAOYSA-N 0.000 description 2
- IJBOVPNSQXXDJB-UHFFFAOYSA-N 3-[2-chloro-4-(2,3-dihydroxypropylamino)-5-nitroanilino]propane-1,2-diol Chemical compound OCC(O)CNC1=CC([N+]([O-])=O)=C(NCC(O)CO)C=C1Cl IJBOVPNSQXXDJB-UHFFFAOYSA-N 0.000 description 2
- UXKLYBMQAHYULT-UHFFFAOYSA-N 4-(2-hydroxyethylamino)-3-nitrophenol Chemical compound OCCNC1=CC=C(O)C=C1[N+]([O-])=O UXKLYBMQAHYULT-UHFFFAOYSA-N 0.000 description 2
- HSDSBIUUVWRHTM-UHFFFAOYSA-N 4-(2-nitroanilino)phenol Chemical compound C1=CC(O)=CC=C1NC1=CC=CC=C1[N+]([O-])=O HSDSBIUUVWRHTM-UHFFFAOYSA-N 0.000 description 2
- LLTDOAPVRPZLCM-UHFFFAOYSA-O 4-(7,8,8,16,16,17-hexamethyl-4,20-disulfo-2-oxa-18-aza-6-azoniapentacyclo[11.7.0.03,11.05,9.015,19]icosa-1(20),3,5,9,11,13,15(19)-heptaen-12-yl)benzoic acid Chemical compound CC1(C)C(C)NC(C(=C2OC3=C(C=4C(C(C(C)[NH+]=4)(C)C)=CC3=3)S(O)(=O)=O)S(O)(=O)=O)=C1C=C2C=3C1=CC=C(C(O)=O)C=C1 LLTDOAPVRPZLCM-UHFFFAOYSA-O 0.000 description 2
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 239000004217 Citranaxanthin Substances 0.000 description 2
- SLQHGWZKKZPZEK-JKEZLOPUSA-N Citranaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)C)C=CC=C(/C)C=CC1=C(C)CCCC1(C)C SLQHGWZKKZPZEK-JKEZLOPUSA-N 0.000 description 2
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 2
- RPWFJAMTCNSJKK-UHFFFAOYSA-N Dodecyl gallate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1 RPWFJAMTCNSJKK-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- XWCYDHJOKKGVHC-UHFFFAOYSA-N Vitamin A2 Chemical compound OCC=C(C)C=CC=C(C)C=CC1=C(C)C=CCC1(C)C XWCYDHJOKKGVHC-UHFFFAOYSA-N 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 229930003537 Vitamin B3 Natural products 0.000 description 2
- 229930003571 Vitamin B5 Natural products 0.000 description 2
- 229930003761 Vitamin B9 Natural products 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 2
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 2
- 239000011717 all-trans-retinol Substances 0.000 description 2
- 235000019169 all-trans-retinol Nutrition 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229940087168 alpha tocopherol Drugs 0.000 description 2
- RZFHLOLGZPDCHJ-DLQZEEBKSA-N alpha-Tocotrienol Natural products Oc1c(C)c(C)c2O[C@@](CC/C=C(/CC/C=C(\CC/C=C(\C)/C)/C)\C)(C)CCc2c1C RZFHLOLGZPDCHJ-DLQZEEBKSA-N 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 2
- 235000013793 astaxanthin Nutrition 0.000 description 2
- 239000001168 astaxanthin Substances 0.000 description 2
- 229940022405 astaxanthin Drugs 0.000 description 2
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 2
- RHDGNLCLDBVESU-UHFFFAOYSA-N but-3-en-4-olide Chemical class O=C1CC=CO1 RHDGNLCLDBVESU-UHFFFAOYSA-N 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 239000001201 calcium disodium ethylene diamine tetra-acetate Substances 0.000 description 2
- 235000011188 calcium disodium ethylene diamine tetraacetate Nutrition 0.000 description 2
- 235000010260 calcium hydrogen sulphite Nutrition 0.000 description 2
- 229960002079 calcium pantothenate Drugs 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000012682 canthaxanthin Nutrition 0.000 description 2
- 239000001659 canthaxanthin Substances 0.000 description 2
- 229940008033 canthaxanthin Drugs 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000019247 citranaxanthin Nutrition 0.000 description 2
- PRDJTOVRIHGKNU-ZWERVMMHSA-N citranaxanthin Chemical compound CC(=O)\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C PRDJTOVRIHGKNU-ZWERVMMHSA-N 0.000 description 2
- PRDJTOVRIHGKNU-UHFFFAOYSA-N citranaxanthine Natural products CC(=O)C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C PRDJTOVRIHGKNU-UHFFFAOYSA-N 0.000 description 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000001177 diphosphate Substances 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- 239000000555 dodecyl gallate Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 235000010350 erythorbic acid Nutrition 0.000 description 2
- XFPHFLGZXKHBMU-UHFFFAOYSA-N ethyl 4-[bis(2-hydroxyethyl)amino]benzoate Chemical compound CCOC(=O)C1=CC=C(N(CCO)CCO)C=C1 XFPHFLGZXKHBMU-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 235000010382 gamma-tocopherol Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- CSFWPUWCSPOLJW-UHFFFAOYSA-N lawsone Chemical compound C1=CC=C2C(=O)C(O)=CC(=O)C2=C1 CSFWPUWCSPOLJW-UHFFFAOYSA-N 0.000 description 2
- 239000012633 leachable Substances 0.000 description 2
- 239000010985 leather Substances 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000004611 light stabiliser Substances 0.000 description 2
- 235000012680 lutein Nutrition 0.000 description 2
- 239000001656 lutein Substances 0.000 description 2
- 229960005375 lutein Drugs 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 2
- 235000012661 lycopene Nutrition 0.000 description 2
- 239000001751 lycopene Substances 0.000 description 2
- 229960004999 lycopene Drugs 0.000 description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 229940094946 palmitoyl tetrapeptide-7 Drugs 0.000 description 2
- 229940115458 pantolactone Drugs 0.000 description 2
- SIEVQTNTRMBCHO-UHFFFAOYSA-N pantolactone Natural products CC1(C)OC(=O)CC1O SIEVQTNTRMBCHO-UHFFFAOYSA-N 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 235000009048 phenolic acids Nutrition 0.000 description 2
- 150000007965 phenolic acids Chemical class 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 235000011176 polyphosphates Nutrition 0.000 description 2
- 239000001508 potassium citrate Substances 0.000 description 2
- 235000011082 potassium citrates Nutrition 0.000 description 2
- 235000010259 potassium hydrogen sulphite Nutrition 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000002207 retinal effect Effects 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- 235000010352 sodium erythorbate Nutrition 0.000 description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 2
- 239000004289 sodium hydrogen sulphite Substances 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 description 2
- 235000010265 sodium sulphite Nutrition 0.000 description 2
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 235000011150 stannous chloride Nutrition 0.000 description 2
- 239000001119 stannous chloride Substances 0.000 description 2
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 2
- 235000010269 sulphur dioxide Nutrition 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 229930003802 tocotrienol Natural products 0.000 description 2
- 239000011731 tocotrienol Substances 0.000 description 2
- 229940068778 tocotrienols Drugs 0.000 description 2
- 235000019148 tocotrienols Nutrition 0.000 description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- AAAQKTZKLRYKHR-UHFFFAOYSA-N triphenylmethane Chemical compound C1=CC=CC=C1C(C=1C=CC=CC=1)C1=CC=CC=C1 AAAQKTZKLRYKHR-UHFFFAOYSA-N 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- 235000011178 triphosphate Nutrition 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 235000019160 vitamin B3 Nutrition 0.000 description 2
- 239000011708 vitamin B3 Substances 0.000 description 2
- 235000009492 vitamin B5 Nutrition 0.000 description 2
- 239000011675 vitamin B5 Substances 0.000 description 2
- 235000019159 vitamin B9 Nutrition 0.000 description 2
- 239000011727 vitamin B9 Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 2
- 235000010930 zeaxanthin Nutrition 0.000 description 2
- 239000001775 zeaxanthin Substances 0.000 description 2
- 229940043269 zeaxanthin Drugs 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- 239000002478 γ-tocopherol Substances 0.000 description 2
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- IHRKJQSLKLYWBQ-QKDODKLFSA-N (2s)-2-[[(2s)-1-[(2s)-5-amino-2-[[2-(hexadecanoylamino)acetyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O IHRKJQSLKLYWBQ-QKDODKLFSA-N 0.000 description 1
- WSGCRSMLXFHGRM-DEVHWETNSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s,3r)-2-[[(2s,3r)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-hydroxypropanoic acid Chemical group CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O WSGCRSMLXFHGRM-DEVHWETNSA-N 0.000 description 1
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 description 1
- RJZNPROJTJSYLC-LLINQDLYSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O RJZNPROJTJSYLC-LLINQDLYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- FGYKUFVNYVMTAM-UHFFFAOYSA-N (R)-2,5,8-trimethyl-2-(4,8,12-trimethyl-trideca-3t,7t,11-trienyl)-chroman-6-ol Natural products OC1=CC(C)=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1C FGYKUFVNYVMTAM-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FBMQNRKSAWNXBT-UHFFFAOYSA-N 1,4-diaminoanthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(N)=CC=C2N FBMQNRKSAWNXBT-UHFFFAOYSA-N 0.000 description 1
- NLXFWUZKOOWWFD-UHFFFAOYSA-N 1-(2-hydroxyethylamino)-4-(methylamino)anthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(NCCO)=CC=C2NC NLXFWUZKOOWWFD-UHFFFAOYSA-N 0.000 description 1
- ICVRBKCRXNVOJC-UHFFFAOYSA-N 1-amino-4-(methylamino)anthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(N)=CC=C2NC ICVRBKCRXNVOJC-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- VHTFHZGAMYUZEP-UHFFFAOYSA-N 2,6,6-Trimethyl-1-cyclohexen-1-acetaldehyde Chemical compound CC1=C(CC=O)C(C)(C)CCC1 VHTFHZGAMYUZEP-UHFFFAOYSA-N 0.000 description 1
- ZEXQZDBPFALETL-UHFFFAOYSA-N 2-(2,4-diamino-6-chloro-3-nitrophenyl)ethanol Chemical compound NC1=CC(Cl)=C(CCO)C(N)=C1[N+]([O-])=O ZEXQZDBPFALETL-UHFFFAOYSA-N 0.000 description 1
- STNOBKHYSBEHCH-UHFFFAOYSA-N 2-(2-amino-4-nitrophenyl)ethylurea Chemical compound NC(=O)NCCC1=CC=C([N+]([O-])=O)C=C1N STNOBKHYSBEHCH-UHFFFAOYSA-N 0.000 description 1
- JILWUYWXYQTKLL-UHFFFAOYSA-N 2-(3-amino-4-methyl-2-nitrophenyl)ethanol Chemical compound CC1=CC=C(CCO)C([N+]([O-])=O)=C1N JILWUYWXYQTKLL-UHFFFAOYSA-N 0.000 description 1
- LGZSBRSLVPLNTM-UHFFFAOYSA-N 2-(4-amino-2-methyl-5-nitroanilino)ethanol Chemical compound CC1=CC(N)=C([N+]([O-])=O)C=C1NCCO LGZSBRSLVPLNTM-UHFFFAOYSA-N 0.000 description 1
- LGGKGPQFSCBUOR-UHFFFAOYSA-N 2-(4-chloro-2-nitroanilino)ethanol Chemical compound OCCNC1=CC=C(Cl)C=C1[N+]([O-])=O LGGKGPQFSCBUOR-UHFFFAOYSA-N 0.000 description 1
- VLZVIIYRNMWPSN-UHFFFAOYSA-N 2-Amino-4-nitrophenol Chemical compound NC1=CC([N+]([O-])=O)=CC=C1O VLZVIIYRNMWPSN-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- WMPGRAUYWYBJKX-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO WMPGRAUYWYBJKX-UHFFFAOYSA-N 0.000 description 1
- FHHDPRNJLKDPEV-UHFFFAOYSA-N 2-[2-amino-4-(2-hydroxyethyl)-3-nitrophenyl]ethanol Chemical compound NC1=C(CCO)C=CC(CCO)=C1[N+]([O-])=O FHHDPRNJLKDPEV-UHFFFAOYSA-N 0.000 description 1
- NZKTVPCPQIEVQT-UHFFFAOYSA-N 2-[4-[(4-aminophenyl)diazenyl]-n-(2-hydroxyethyl)anilino]ethanol Chemical compound C1=CC(N)=CC=C1N=NC1=CC=C(N(CCO)CCO)C=C1 NZKTVPCPQIEVQT-UHFFFAOYSA-N 0.000 description 1
- LMKFATMCEGPAPC-UHFFFAOYSA-N 2-[4-amino-n-(2-hydroxyethyl)-2-nitroanilino]ethanol Chemical compound NC1=CC=C(N(CCO)CCO)C([N+]([O-])=O)=C1 LMKFATMCEGPAPC-UHFFFAOYSA-N 0.000 description 1
- VOLCMGPDRGNUGR-UHFFFAOYSA-N 2-[4-amino-n-(2-hydroxyethyl)-3-nitroanilino]ethanol Chemical compound NC1=CC=C(N(CCO)CCO)C=C1[N+]([O-])=O VOLCMGPDRGNUGR-UHFFFAOYSA-N 0.000 description 1
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 1
- CDFNUSAXZDSXKF-UHFFFAOYSA-N 2-chloro-6-(ethylamino)-4-nitrophenol Chemical compound CCNC1=CC([N+]([O-])=O)=CC(Cl)=C1O CDFNUSAXZDSXKF-UHFFFAOYSA-N 0.000 description 1
- FZZMTSNZRBFGGU-UHFFFAOYSA-N 2-chloro-7-fluoroquinazolin-4-amine Chemical compound FC1=CC=C2C(N)=NC(Cl)=NC2=C1 FZZMTSNZRBFGGU-UHFFFAOYSA-N 0.000 description 1
- MXCDRFGKHNFKIP-UHFFFAOYSA-N 2-hydroxy-5-[(4-sulfophenyl)diazenyl]benzoic acid Chemical compound C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(O)(=O)=O)=C1 MXCDRFGKHNFKIP-UHFFFAOYSA-N 0.000 description 1
- LRHFWTSUYLXTPU-UHFFFAOYSA-N 2-methoxy-2h-furan-5-one Chemical compound COC1OC(=O)C=C1 LRHFWTSUYLXTPU-UHFFFAOYSA-N 0.000 description 1
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 1
- HVHNMNGARPCGGD-UHFFFAOYSA-N 2-nitro-p-phenylenediamine Chemical compound NC1=CC=C(N)C([N+]([O-])=O)=C1 HVHNMNGARPCGGD-UHFFFAOYSA-N 0.000 description 1
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 1
- ODADKLYLWWCHNB-UHFFFAOYSA-N 2R-delta-tocotrienol Natural products OC1=CC(C)=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 ODADKLYLWWCHNB-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- XDHQHBSDKYPJRG-UHFFFAOYSA-N 3-[2-nitro-4-(trifluoromethyl)anilino]propane-1,2-diol Chemical compound OCC(O)CNC1=CC=C(C(F)(F)F)C=C1[N+]([O-])=O XDHQHBSDKYPJRG-UHFFFAOYSA-N 0.000 description 1
- SIYKOUNMJAUPEV-UHFFFAOYSA-N 3-amino-2-(2-hydroxyethyl)-4,6-dinitrophenol Chemical compound NC1=C(CCO)C(O)=C([N+]([O-])=O)C=C1[N+]([O-])=O SIYKOUNMJAUPEV-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- NBGQZFQREPIKMG-UHFFFAOYSA-N 3beta-hydroxy-beta-boswellic acid Natural products C1CC(O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C NBGQZFQREPIKMG-UHFFFAOYSA-N 0.000 description 1
- UNBOSJFEZZJZLR-UHFFFAOYSA-N 4-(4-nitrophenylazo)aniline Chemical compound C1=CC(N)=CC=C1N=NC1=CC=C([N+]([O-])=O)C=C1 UNBOSJFEZZJZLR-UHFFFAOYSA-N 0.000 description 1
- XPLTXYDVYDWSSO-UHFFFAOYSA-N 4-(ethylamino)-3-nitrobenzoic acid Chemical compound CCNC1=CC=C(C(O)=O)C=C1[N+]([O-])=O XPLTXYDVYDWSSO-UHFFFAOYSA-N 0.000 description 1
- KEVCVWPVGPWWOI-UHFFFAOYSA-N 4-[(1,3-dimethylimidazol-1-ium-2-yl)diazenyl]aniline;chloride Chemical compound [Cl-].CN1C=C[N+](C)=C1N=NC1=CC=C(N)C=C1 KEVCVWPVGPWWOI-UHFFFAOYSA-N 0.000 description 1
- AXDJCCTWPBKUKL-UHFFFAOYSA-N 4-[(4-aminophenyl)-(4-imino-3-methylcyclohexa-2,5-dien-1-ylidene)methyl]aniline;hydron;chloride Chemical compound Cl.C1=CC(=N)C(C)=CC1=C(C=1C=CC(N)=CC=1)C1=CC=C(N)C=C1 AXDJCCTWPBKUKL-UHFFFAOYSA-N 0.000 description 1
- AARXMLGCTGYZTD-UHFFFAOYSA-N 5-(1h-imidazol-5-yl)pentanoic acid Chemical compound OC(=O)CCCCC1=CN=CN1 AARXMLGCTGYZTD-UHFFFAOYSA-N 0.000 description 1
- NSISJFFVIMQBRN-UHFFFAOYSA-N 5-(hydroxymethyl)oxolan-2-one Chemical compound OCC1CCC(=O)O1 NSISJFFVIMQBRN-UHFFFAOYSA-N 0.000 description 1
- ZVDCYZVYRXZJQF-UHFFFAOYSA-N 6-nitro-1,2,3,4-tetrahydroquinoxaline Chemical compound N1CCNC2=CC([N+](=O)[O-])=CC=C21 ZVDCYZVYRXZJQF-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- CQPFMGBJSMSXLP-ZAGWXBKKSA-M Acid orange 7 Chemical compound OC1=C(C2=CC=CC=C2C=C1)/N=N/C1=CC=C(C=C1)S(=O)(=O)[O-].[Na+] CQPFMGBJSMSXLP-ZAGWXBKKSA-M 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- HAUGRYOERYOXHX-UHFFFAOYSA-N Alloxazine Chemical compound C1=CC=C2N=C(C(=O)NC(=O)N3)C3=NC2=C1 HAUGRYOERYOXHX-UHFFFAOYSA-N 0.000 description 1
- AOMZHDJXSYHPKS-DROYEMJCSA-L Amido Black 10B Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC2=CC(S([O-])(=O)=O)=C(\N=N\C=3C=CC=CC=3)C(O)=C2C(N)=C1\N=N\C1=CC=C(N(=O)=O)C=C1 AOMZHDJXSYHPKS-DROYEMJCSA-L 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- JQFZHHSQMKZLRU-IUCAKERBSA-N Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N JQFZHHSQMKZLRU-IUCAKERBSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- CKAJHWFHHFSCDT-WHFBIAKZSA-N Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O CKAJHWFHHFSCDT-WHFBIAKZSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000351920 Aspergillus nidulans Species 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- RAFGELQLHMBRHD-VFYVRILKSA-N Bixin Natural products COC(=O)C=CC(=C/C=C/C(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)/C)C RAFGELQLHMBRHD-VFYVRILKSA-N 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- NBGQZFQREPIKMG-PONOSELZSA-N Boswellic acid Chemical compound C1C[C@@H](O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C NBGQZFQREPIKMG-PONOSELZSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 244000147935 Condalia obovata Species 0.000 description 1
- 235000008317 Condalia obovata Nutrition 0.000 description 1
- 244000251987 Coprinus macrorhizus Species 0.000 description 1
- 235000001673 Coprinus macrorhizus Nutrition 0.000 description 1
- 239000004212 Cryptoxanthin Substances 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- YXQDRIRSAHTJKM-IMJSIDKUSA-N Cys-Ser Chemical compound SC[C@H](N)C(=O)N[C@@H](CO)C(O)=O YXQDRIRSAHTJKM-IMJSIDKUSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-isoascorbic acid Chemical compound OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- 108010046331 Deoxyribodipyrimidine photo-lyase Proteins 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108010013369 Enteropeptidase Proteins 0.000 description 1
- 102100029727 Enteropeptidase Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- 108010074860 Factor Xa Proteins 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- PNENOUKIPPERMY-UHFFFAOYSA-N HC Yellow No. 4 Chemical compound OCCNC1=CC=C([N+]([O-])=O)C=C1OCCO PNENOUKIPPERMY-UHFFFAOYSA-N 0.000 description 1
- 244000249914 Hemigraphis reptans Species 0.000 description 1
- WSDOHRLQDGAOGU-BQBZGAKWSA-N His-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 WSDOHRLQDGAOGU-BQBZGAKWSA-N 0.000 description 1
- 101000881168 Homo sapiens SPARC Proteins 0.000 description 1
- XPJVKCRENWUEJH-UHFFFAOYSA-N Isobutylparaben Chemical compound CC(C)COC(=O)C1=CC=C(O)C=C1 XPJVKCRENWUEJH-UHFFFAOYSA-N 0.000 description 1
- RWSXRVCMGQZWBV-PHDIDXHHSA-N L-Glutathione Natural products OC(=O)[C@H](N)CCC(=O)N[C@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-PHDIDXHHSA-N 0.000 description 1
- 125000000998 L-alanino group Chemical group [H]N([*])[C@](C([H])([H])[H])([H])C(=O)O[H] 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 125000000393 L-methionino group Chemical group [H]OC(=O)[C@@]([H])(N([H])[*])C([H])([H])C(SC([H])([H])[H])([H])[H] 0.000 description 1
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 description 1
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
- 108010023244 Lactoperoxidase Proteins 0.000 description 1
- 102000045576 Lactoperoxidases Human genes 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 108010064699 MSH Release-Inhibiting Hormone Proteins 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- NOOJLZTTWSNHOX-UWVGGRQHSA-N Melanostatin Chemical compound NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 NOOJLZTTWSNHOX-UWVGGRQHSA-N 0.000 description 1
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- LHHPUJBYGSGIEZ-UHFFFAOYSA-N NCCC[N+]1(CCOCC1)C.OC1=CC=CC=2C(C3=CC=CC=C3C(C12)=O)=O Chemical compound NCCC[N+]1(CCOCC1)C.OC1=CC=CC=2C(C3=CC=CC=C3C(C12)=O)=O LHHPUJBYGSGIEZ-UHFFFAOYSA-N 0.000 description 1
- 241000123069 Ocyurus chrysurus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004285 Potassium sulphite Substances 0.000 description 1
- 101000621511 Potato virus M (strain German) RNA silencing suppressor Proteins 0.000 description 1
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 241001510071 Pyrrhocoridae Species 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- UEJYSALTSUZXFV-SRVKXCTJSA-N Rigin Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O UEJYSALTSUZXFV-SRVKXCTJSA-N 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- 102100037599 SPARC Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 241001136490 Thermomyces dupontii Species 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- GXDLGHLJTHMDII-WISUUJSJSA-N Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(O)=O GXDLGHLJTHMDII-WISUUJSJSA-N 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical group OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- TYYLDKGBCJGJGW-WMZOPIPTSA-N Trp-Tyr Chemical compound C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)N)C(O)=O)C1=CC=C(O)C=C1 TYYLDKGBCJGJGW-WMZOPIPTSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- BMPPMAOOKQJYIP-WMZOPIPTSA-N Tyr-Trp Chemical compound C([C@H]([NH3+])C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C([O-])=O)C1=CC=C(O)C=C1 BMPPMAOOKQJYIP-WMZOPIPTSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- UXEAWNJALIUYRH-UHFFFAOYSA-N [8-[(4-aminophenyl)hydrazinylidene]-7-oxonaphthalen-2-yl]-trimethylazanium;chloride Chemical compound [Cl-].C12=CC([N+](C)(C)C)=CC=C2C=CC(=O)\C1=N/NC1=CC=C(N)C=C1 UXEAWNJALIUYRH-UHFFFAOYSA-N 0.000 description 1
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 229940019789 acid black 52 Drugs 0.000 description 1
- 229940099540 acid violet 43 Drugs 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229930002945 all-trans-retinaldehyde Natural products 0.000 description 1
- 229940100609 all-trans-retinol Drugs 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 229940064063 alpha tocotrienol Drugs 0.000 description 1
- RAFGELQLHMBRHD-UHFFFAOYSA-N alpha-Fuc-(1-2)-beta-Gal-(1-3)-(beta-GlcNAc-(1-6))-GalNAc-ol Natural products COC(=O)C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC(O)=O RAFGELQLHMBRHD-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000001670 anatto Substances 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 235000012665 annatto Nutrition 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000000987 azo dye Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 description 1
- 229940075506 behentrimonium chloride Drugs 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- FGYKUFVNYVMTAM-YMCDKREISA-N beta-Tocotrienol Natural products Oc1c(C)c2c(c(C)c1)O[C@@](CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)(C)CC2 FGYKUFVNYVMTAM-YMCDKREISA-N 0.000 description 1
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 1
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- RAFGELQLHMBRHD-SLEZCNMESA-N bixin Chemical compound COC(=O)\C=C\C(\C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C(O)=O RAFGELQLHMBRHD-SLEZCNMESA-N 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- GEHJBWKLJVFKPS-UHFFFAOYSA-N bromochloroacetic acid Chemical compound OC(=O)C(Cl)Br GEHJBWKLJVFKPS-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- HOWJQLVNDUGZBI-UHFFFAOYSA-N butane;propane Chemical compound CCC.CCCC HOWJQLVNDUGZBI-UHFFFAOYSA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000010376 calcium ascorbate Nutrition 0.000 description 1
- 239000011692 calcium ascorbate Substances 0.000 description 1
- LVGQIQHJMRUCRM-UHFFFAOYSA-L calcium bisulfite Chemical compound [Ca+2].OS([O-])=O.OS([O-])=O LVGQIQHJMRUCRM-UHFFFAOYSA-L 0.000 description 1
- 239000004294 calcium hydrogen sulphite Substances 0.000 description 1
- 239000001175 calcium sulphate Substances 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- 239000004295 calcium sulphite Substances 0.000 description 1
- 235000010261 calcium sulphite Nutrition 0.000 description 1
- 239000002967 calcium-L-ascorbate Substances 0.000 description 1
- 235000005937 calcium-L-ascorbate Nutrition 0.000 description 1
- SHWNNYZBHZIQQV-UHFFFAOYSA-L calcium;disodium;2-[2-[bis(carboxylatomethyl)azaniumyl]ethyl-(carboxylatomethyl)azaniumyl]acetate Chemical compound [Na+].[Na+].[Ca+2].[O-]C(=O)C[NH+](CC([O-])=O)CC[NH+](CC([O-])=O)CC([O-])=O SHWNNYZBHZIQQV-UHFFFAOYSA-L 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229960002788 cetrimonium chloride Drugs 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229940010007 cobalamins Drugs 0.000 description 1
- 150000001867 cobalamins Chemical class 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 230000003766 combability Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000994 contrast dye Substances 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 239000003581 cosmetic carrier Substances 0.000 description 1
- 239000000973 cosmetic coloring agent Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 235000019244 cryptoxanthin Nutrition 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- BTNBMQIHCRIGOU-UHFFFAOYSA-N delta-tocotrienol Natural products CC(=CCCC(=CCCC(=CCCOC1(C)CCc2cc(O)cc(C)c2O1)C)C)C BTNBMQIHCRIGOU-UHFFFAOYSA-N 0.000 description 1
- 239000001025 demi permanent hair color Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229940077445 dimethyl ether Drugs 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical class [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- LQJVOKWHGUAUHK-UHFFFAOYSA-L disodium 5-amino-4-hydroxy-3-phenyldiazenylnaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].OC1=C2C(N)=CC(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=C1N=NC1=CC=CC=C1 LQJVOKWHGUAUHK-UHFFFAOYSA-L 0.000 description 1
- KAKKHKRHCKCAGH-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate;hexahydrate Chemical compound O.O.O.O.O.O.[Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 KAKKHKRHCKCAGH-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940080643 dodecyl gallate Drugs 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- FGYKUFVNYVMTAM-MUUNZHRXSA-N epsilon-Tocopherol Natural products OC1=CC(C)=C2O[C@@](CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1C FGYKUFVNYVMTAM-MUUNZHRXSA-N 0.000 description 1
- 239000004318 erythorbic acid Substances 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010944 ethyl methyl cellulose Nutrition 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000542 fatty acid esters of ascorbic acid Substances 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- OTXNTMVVOOBZCV-YMCDKREISA-N gamma-Tocotrienol Natural products Oc1c(C)c(C)c2O[C@@](CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)(C)CCc2c1 OTXNTMVVOOBZCV-YMCDKREISA-N 0.000 description 1
- NSISJFFVIMQBRN-SCSAIBSYSA-N gamma-hydroxymethyl-gamma-butyrolactone Natural products OC[C@H]1CCC(=O)O1 NSISJFFVIMQBRN-SCSAIBSYSA-N 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960000587 glutaral Drugs 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 235000012701 green S Nutrition 0.000 description 1
- WDPIZEKLJKBSOZ-UHFFFAOYSA-M green s Chemical compound [Na+].C1=CC(N(C)C)=CC=C1C(C=1C2=CC=C(C=C2C=C(C=1O)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](C)C)C=C1 WDPIZEKLJKBSOZ-UHFFFAOYSA-M 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 231100000640 hair analysis Toxicity 0.000 description 1
- 210000004919 hair shaft Anatomy 0.000 description 1
- 230000003806 hair structure Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 210000003284 horn Anatomy 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 238000002169 hydrotherapy Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- 229940035415 isobutane Drugs 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229940057428 lactoperoxidase Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- NYGZLYXAPMMJTE-UHFFFAOYSA-M metanil yellow Chemical compound [Na+].[O-]S(=O)(=O)C1=CC=CC(N=NC=2C=CC(NC=3C=CC=CC=3)=CC=2)=C1 NYGZLYXAPMMJTE-UHFFFAOYSA-M 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- CBKLICUQYUTWQL-XWGBWKJCSA-N methyl (3s,4r)-3-methyl-1-(2-phenylethyl)-4-(n-propanoylanilino)piperidine-4-carboxylate;oxalic acid Chemical compound OC(=O)C(O)=O.CCC(=O)N([C@]1([C@H](CN(CCC=2C=CC=CC=2)CC1)C)C(=O)OC)C1=CC=CC=C1 CBKLICUQYUTWQL-XWGBWKJCSA-N 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229920003087 methylethyl cellulose Polymers 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- FYTRVVJHEWUARG-UHFFFAOYSA-N n-(2-aminophenyl)nitramide Chemical class NC1=CC=CC=C1N[N+]([O-])=O FYTRVVJHEWUARG-UHFFFAOYSA-N 0.000 description 1
- DZQXQAXLDXJEAG-UHFFFAOYSA-N n-(2-hydroxyphenyl)nitramide Chemical class OC1=CC=CC=C1N[N+]([O-])=O DZQXQAXLDXJEAG-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- LLLILZLFKGJCCV-UHFFFAOYSA-M n-methyl-n-[(1-methylpyridin-1-ium-4-yl)methylideneamino]aniline;methyl sulfate Chemical compound COS([O-])(=O)=O.C=1C=CC=CC=1N(C)\N=C\C1=CC=[N+](C)C=C1 LLLILZLFKGJCCV-UHFFFAOYSA-M 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- CTIQLGJVGNGFEW-UHFFFAOYSA-L naphthol yellow S Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C([O-])=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 CTIQLGJVGNGFEW-UHFFFAOYSA-L 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- NRPKURNSADTHLJ-UHFFFAOYSA-N octyl gallate Chemical compound CCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1 NRPKURNSADTHLJ-UHFFFAOYSA-N 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 238000005691 oxidative coupling reaction Methods 0.000 description 1
- 125000000369 oxido group Chemical group [*]=O 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 150000002942 palmitic acid derivatives Chemical class 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- QXYMVUZOGFVPGH-UHFFFAOYSA-N picramic acid Chemical compound NC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O QXYMVUZOGFVPGH-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002704 polyhistidine Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- DJEHXEMURTVAOE-UHFFFAOYSA-M potassium bisulfite Chemical compound [K+].OS([O-])=O DJEHXEMURTVAOE-UHFFFAOYSA-M 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 239000004293 potassium hydrogen sulphite Substances 0.000 description 1
- 239000004297 potassium metabisulphite Substances 0.000 description 1
- 235000010263 potassium metabisulphite Nutrition 0.000 description 1
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 1
- 235000019252 potassium sulphite Nutrition 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 125000002050 pyridoxal group Chemical group 0.000 description 1
- 150000003223 pyridoxals Chemical class 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 150000003287 riboflavins Chemical class 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 108010091078 rigin Proteins 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- YRWWOAFMPXPHEJ-OFBPEYICSA-K sodium L-ascorbic acid 2-phosphate Chemical compound [Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] YRWWOAFMPXPHEJ-OFBPEYICSA-K 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229940048058 sodium ascorbyl phosphate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000004320 sodium erythorbate Substances 0.000 description 1
- LDTLADDKFLAYJA-UHFFFAOYSA-L sodium metabisulphite Chemical compound [Na+].[Na+].[O-]S(=O)OS([O-])=O LDTLADDKFLAYJA-UHFFFAOYSA-L 0.000 description 1
- 239000004296 sodium metabisulphite Substances 0.000 description 1
- 239000011755 sodium-L-ascorbate Substances 0.000 description 1
- 235000019187 sodium-L-ascorbate Nutrition 0.000 description 1
- GTKIEPUIFBBXJQ-UHFFFAOYSA-M sodium;2-[(4-hydroxy-9,10-dioxoanthracen-1-yl)amino]-5-methylbenzenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC1=CC=C(O)C2=C1C(=O)C1=CC=CC=C1C2=O GTKIEPUIFBBXJQ-UHFFFAOYSA-M 0.000 description 1
- FTUYQIPAPWPHNC-UHFFFAOYSA-M sodium;4-[[4-[benzyl(ethyl)amino]phenyl]-[4-[benzyl(ethyl)azaniumylidene]cyclohexa-2,5-dien-1-ylidene]methyl]benzene-1,3-disulfonate Chemical compound [Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=CC=CC=2)C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC=C1 FTUYQIPAPWPHNC-UHFFFAOYSA-M 0.000 description 1
- NHZIBLPDGIARQC-UHFFFAOYSA-M sodium;4-hydroxy-5-(2-hydroxy-4-methoxybenzoyl)-2-methoxybenzenesulfonate Chemical compound [Na+].OC1=CC(OC)=CC=C1C(=O)C1=CC(S([O-])(=O)=O)=C(OC)C=C1O NHZIBLPDGIARQC-UHFFFAOYSA-M 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 239000001590 sorbitan monolaureate Substances 0.000 description 1
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940100459 steareth-20 Drugs 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000004291 sulphur dioxide Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000012756 tartrazine Nutrition 0.000 description 1
- 239000004149 tartrazine Substances 0.000 description 1
- UJMBCXLDXJUMFB-GLCFPVLVSA-K tartrazine Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-GLCFPVLVSA-K 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 230000019432 tissue death Effects 0.000 description 1
- 239000000541 tocopherol-rich extract Substances 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 229940077400 trideceth-12 Drugs 0.000 description 1
- DWKARHJHPSUOBW-UHFFFAOYSA-N trimethyl-[3-[(2e)-2-(3-methyl-5-oxo-1-phenylpyrazol-4-ylidene)hydrazinyl]phenyl]azanium;chloride Chemical compound [Cl-].CC1=NN(C=2C=CC=CC=2)C(O)=C1N=NC1=CC=CC([N+](C)(C)C)=C1 DWKARHJHPSUOBW-UHFFFAOYSA-N 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 108010044292 tryptophyltyrosine Proteins 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- LLWJPGAKXJBKKA-UHFFFAOYSA-N victoria blue B Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC(=CC=1)N(C)C)=C(C=C1)C2=CC=CC=C2C1=[NH+]C1=CC=CC=C1 LLWJPGAKXJBKKA-UHFFFAOYSA-N 0.000 description 1
- ROVRRJSRRSGUOL-UHFFFAOYSA-N victoria blue bo Chemical compound [Cl-].C12=CC=CC=C2C(NCC)=CC=C1C(C=1C=CC(=CC=1)N(CC)CC)=C1C=CC(=[N+](CC)CC)C=C1 ROVRRJSRRSGUOL-UHFFFAOYSA-N 0.000 description 1
- 150000004370 vitamin A ester derivatives Chemical class 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000021467 vitamin B7(Biotin) Nutrition 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 150000003703 vitamin D2 derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045999 vitamin b 12 Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- RZFHLOLGZPDCHJ-XZXLULOTSA-N α-Tocotrienol Chemical compound OC1=C(C)C(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1C RZFHLOLGZPDCHJ-XZXLULOTSA-N 0.000 description 1
- 235000019145 α-tocotrienol Nutrition 0.000 description 1
- 239000011730 α-tocotrienol Substances 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 235000019151 β-tocotrienol Nutrition 0.000 description 1
- 239000011723 β-tocotrienol Substances 0.000 description 1
- FGYKUFVNYVMTAM-WAZJVIJMSA-N β-tocotrienol Chemical compound OC1=CC(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1C FGYKUFVNYVMTAM-WAZJVIJMSA-N 0.000 description 1
- 235000019150 γ-tocotrienol Nutrition 0.000 description 1
- 239000011722 γ-tocotrienol Substances 0.000 description 1
- OTXNTMVVOOBZCV-WAZJVIJMSA-N γ-tocotrienol Chemical compound OC1=C(C)C(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 OTXNTMVVOOBZCV-WAZJVIJMSA-N 0.000 description 1
- 235000019144 δ-tocotrienol Nutrition 0.000 description 1
- 239000011729 δ-tocotrienol Substances 0.000 description 1
- ODADKLYLWWCHNB-LDYBVBFYSA-N δ-tocotrienol Chemical compound OC1=CC(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 ODADKLYLWWCHNB-LDYBVBFYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
- A61Q5/065—Preparations for temporary colouring the hair, e.g. direct dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
Definitions
- the present invention relates to the use of hydrophobin in the non-permanent dyeing of keratin and keratin-containing materials, especially hair, and a corresponding method of non-permanent dyeing of keratin and keratin-containing materials, especially hair. It also relates to non-permanent staining of keratin and keratin-containing materials, especially hair, containing hydrophobin.
- Means for coloring or tinting hair are classified according to the stability of the dyeing. There are several classifications known. Usually, a subdivision into three classes: temporary hair dyes (tints in the strict sense) that last only 1-2 hair washes (level 1), semi-permanent
- Levels 1 and 2 have in common in all of the classifications that they are washable, so they are collectively referred to herein as leachable or non-permanent dyes.
- Semi- and demipermanent stains are summarized below as stains of stage 2, while tints of stage 1 are referred to colors washed out after 1-2 washes.
- All commercial products for the permanent dyeing of hair of level 3 contain on the one hand a "developer", usually an oxidizing chemical, and on the other hand an alkaline component as part of their dye paste, usually ammonia or an ammonia substitute such as monoethanolamine.
- Permanent hair dyes are also referred to as oxidative hair dyes due to this chemical process.
- the permanent hair dyes also include the so-called "self-oxidizing dyes", which are oxidized by atmospheric oxygen.
- non-permanent hair dyes are generally non-oxidative.
- the dye molecules are arranged on the surface of the keratin or penetrate only a small distance into the hair. They are too big to penetrate the hair completely.
- the resulting dye layer can be removed by washing with hair shampoo.
- Level 1 acidic dyes are usually used, which have only a low affinity for the hair and rather accumulate on the surface of the hair.
- the dyes in tints are generally either positively charged and then bind to negatively charged surface groups of the hair, or they are small molecules that can penetrate into the cuticle.
- the hair shaft itself is not penetrated by temporary hair colors. Instead, these dyes remain attached to the cuticle and can often be removed with a single hair wash.
- semipermanent hair colors can penetrate the hair because they contain smaller color molecules than the temporary hair tints. Therefore, semipermanent hair dyes last longer than temporary tints and usually need to be renewed after 8 to 10 washes. Demipermanent dyeings, whose dyes penetrate even better into the hair, last much longer, usually up to 24 washes.
- tints by the suppliers, often even as tints of level 1, although they should be more appropriately classified as level 2.
- Hair dyes are normally sold in the form of aqueous, concentrated solutions or emulsions and contain, in addition to the actual dyes, e.g. Fatty acid alcohols and / or other oil components, emulsifiers and surfactants, and optionally alcohols. Tints and semipermanent hair dyes are available in various product forms, i.a. as pastes, rinses, shampoos, gels and sprays.
- Non-permanent hair dyes have a lower market share than permanent hair colors. They are nevertheless of high economic interest because they attack the hair less than permanent hair colors and do not bleach. still contain ammonia. In addition, because of some of their ingredients, especially hydrogen peroxide and ammonia, permanent hair colors have been under criticism for quite some time. Permanent paints that have not been tested for compatibility will be banned even in the EU in the future.
- non-permanent hair dyes and methods that provide an alternative or enhancement to the existing non-permanent hair colorants and methods and, in particular, allow more stable binding of the dye to the hair as much as possible without causing damage to the hair ,
- Hydrophobins are a class of small, cysteine-rich proteins about 100-150 amino acids in length, which in nature occur only in filamentous fungi. They are amphiphilic and can form a water-insoluble layer on the surface of an article. Their natural functions include the coating of fungal spores so that they do not stick together, the coating of aerial hyphae to reduce the surface tension of water and thus to facilitate water absorption, and possibly the Signal transduction between a fungus and its environment (Whiteford, JF Spanu, PD (2001), Fungal Genet., Biol. 32 (3): 159-168; Wösten et al. (1999) Current Biol. 19: 1985-88; Bell et al., (1992) Genes Dev. 6: 2382-2394).
- hydrophobin genes have been identified in ascomycetes, deuteromycetes and basiodiomycetes.
- Some fungi contain more than one hydrophobin gene, e.g. Schizophyllum commune, Coprinus cinereus and Aspergillus nidulans.
- hydrophobins of one class can to a certain extent functionally replace hydrophobins of the other class.
- the various hydrophobins appear to be involved in different fungal development stages and to perform different functions therein (van Wetter et al (2000) Mol Microbiol 36: 201-210, Kershaw et al (1998) Fungal Genet., Biol. 23: 18 -33).
- Hydrophobins usually have eight cysteine units. They can be isolated from natural sources, but can also be obtained by means of genetic engineering processes, as described, for example, in WO 2006/082251 and WO 2006/131564.
- hydrophobin in cosmetic preparations is known per se.
- US 2003/0217419 A1 describes the use of the SC 3 hydrophobin from S. ses for the treatment of keratin-containing materials. This forms cosmetic depots that should withstand several washes with shampoo.
- the hydrophobin is applied either simultaneously or after the cosmetically active ingredient, but not before applying the cosmetic ingredient.
- WO 2006/136607 A2 describes the use of hydrophobin and of hydrophobin conjugates in cosmetic preparations for hair care.
- hydrophobins can be linked to semi-permanent or permanent hair dyes and increase their concentration and action on the skin and hair.
- permanent hair dyes one of the two dye components is bound to the hydrophobin while the other component is added to the hair after application of the conjugate. The oxidative coupling of both components then happens directly on the hair.
- the use of hydrophobin together with temporary hair dyes of stage 1 does not describe WO 2006/136607.
- WO 2006/082251 describes hydrophobin proteins, their production and their use for surface coating.
- WO 96/41882 proposes the use of hydrophobins, inter alia, as surface-active substances, for hydrophilizing hydrophobic surfaces, for improving the water resistance of hydrophilic substrates and for producing hair shampoos and rinses.
- non-permanent dyeing in particular the tinting or semi-permanent dyeing of keratin and keratin-containing materials (such as hair, skin and nails, but also wool, leather and other keratinous materials). containing textiles), especially of hair.
- Another object is to provide a method of keratin staining, especially hair coloring, in which the keratin fiber is damaged as little as possible.
- the dyeing of keratin made possible by the present invention should preferably be non-permanent, but exceed in their resistance and / or color intensity the hitherto available non-permanent, in particular temporary, hair dyeings.
- the aim is further to improve the coloration of keratin by conventional non-permanent colorants, in particular to increase the color intensity and / or the resistance to tinting or dyeing without the need for the use of oxidative dyes.
- This goal is preferably sought for tints and semi-permeable dyeings. This is intended to provide an alternative to permanent colorants which does not have the disadvantages of these colorants.
- the present invention relates to the use of hydrophobin and hydrophobin-containing compositions in the non-permanent dyeing of keratin or keratin-containing material, especially hair. It further relates to a corresponding composition for coloring keratin, especially a tint or semi-permanent color. A similar method of staining keratin using hydrophobin is also presented.
- hydrophobin preferably leads to a higher color intensity and a longer washing time of the dyeing, which suggests an improved uptake and / or addition of non-permanent dyes into / on the keratin. This applies in particular to hydrophilic dyes. The coloring becomes more intense and / or longer lasting.
- hydrophobin may further result in improved uptake and / or addition of other cosmetic actives (besides the non-permanent dyes) into / on the keratin.
- This preferably relates to hydrophilic cosmetically active ingredients, such as panthenol.
- the active ingredients are thus more intense, because they arrive in higher local concentration and / or in the keratin and / or the time to complete washing out of these substances is prolonged. This can have an effect on the hair thickness, tear resistance (tensile strength improvement), combability and combing power, suppleness and other properties of the treated keratin.
- the respective quantitative and qualitative effects are determined by the individual cosmetic active ingredients and their field of application.
- other constituents of tints / colorations in addition to the dyes, such as care substances can also act more intense by the presence of hydrophobin.
- the present invention relates to the following subjects or embodiments:
- a method of non-permanent staining of keratin or keratin containing material comprising applying at least one non-permanent dye and at least one hydrophobin of structural formula (I) to the keratin or keratin containing material;
- composition containing at least one hydrophobin of formula (I) (i) a composition containing at least one hydrophobin of formula (I), and (ii) a composition containing at least one non-permanent
- a hydrophobin may also encompass more than one hydrophobin molecule, namely, two, three, four, five, etc. hydrophobins of a variety.
- At least one means “one or more”, “at least” followed by a numerical value means "this or a higher numerical value”.
- acids are present either as the free acid or as a partial or complete salt of the acid or as a mixture of the acid with its salt.
- bases especially amines, may be present as the free base or as a partial or complete salt of the base or as a mixture of the base with its salt.
- “Native” is synonymous with “wild type” and “naturally occurring”.
- a “naturally” occurring linkage of two polypeptides is a linkage as it is found in naturam, that is, for example, in a wild-type protein.
- a wild-type or native protein or polypeptide is - unless otherwise stated indicated - the usually naturally occurring form of this protein / polypeptide.
- a "fragment" of an amino acid sequence results from the absence of one or more consecutive amino acids at the N and / or C terminus of said original sequence.
- a "homologue" of an amino acid sequence in the context of the present invention is a protein or polypeptide which differs from the original sequence by the substitution of one or more amino acids.
- the function and / or conformation of the protein is not affected by this substitution.
- the amino acid substitution is a conservative amino acid substitution, so the exchanged amino acids are replaced by amino acids with similar chemical properties, e.g. VaI by AIa.
- conservative amino acid exchanges occur between the members of the following groups: acidic amino acids (aspartate and glutamic acid); basic amino acids (lysine, arginine, histidine); hydrophobic amino acids (leucine, isoleucine, methionine, valine, alanine); hydrophilic amino acids (serine, glycine, alanine, threonine); Amino acids with aliphatic side chains (glycine, alanine, valine, leucine,
- Amino acids with amide groups in the side chain (asparagine, glutamine); Amino acids with aromatic side chains (phenylalanine, tyrosine, tryptophan);
- isolated means "separated or purified from the parent organism". An isolated hydrophobin is therefore no longer part of the fungus in which it occurs in nature. Recombinantly produced hydrophobins are also 'iso lated' 'hydrophobins.
- Color Intensity is the perceived chroma which can be determined either by subjective evaluation on the face-up (if necessary in comparison with a non-stained standard), or by comparison of optical measurement data.
- measurement data can be determined, for example, by means of a conventional photometer or colorimeter, such as the Konica Minolta CR-300, CR-310, CR-311 (Konica Minolta Sensing, Inc., Osaka, Japan), preferably with the CR-300.
- the measured data can then be selected, for example, according to the abL system (synonym: Lab system, CIELAB system, L: brightness, a: color, b: saturation) or according to the L * a * b * system (CIE 1976) according to the L * a * b * system.
- the evaluation according to the L * a * b * system is described, for example, in the instruction manual of the Konica Minolta CR-300, CR-310, CR-311 (Konica Minolta Sensing, Inc., Osaka, Japan), German version, version number 527 349 /9.99.
- non-permanent dye refers to a dye whose staining effect on keratin can be reversed by single or multiple washout, ie a dye for non-permanent staining of keratin.
- non-permanent / washable dye and “non-permanent / washable (hair) colorant” in the context of the present invention include tints, semi-and demipermanent dyes and keratin stainers, ie, all stains and stains that are leachable from keratin or no permanent hair dye.
- tint is used in the context of the present invention synonymously with “temporary tint”, “temporary tinting agent”, “temporary tinting”, “temporary tinting”. Due to the non-uniform language usage of the manufacturer (see above, background), in its further meaning it includes all non-permanent, washable hair colorants, ie temporary colorants (tints in the true sense), semi- and demipermanent colorants. In the narrower, preferred sense it includes tints and semi-permanent colorants, in the most preferred and narrowest sense tints in the true sense. A tint in the true sense is a means for nonpermanent coloring of hair that can be washed out by 1-2 washes. Further definitions and explanations can be found in the section "Background”.
- ⁇ E (synonym: Delta E ”) is a measure of the color difference or the color difference (DIN 5033-1: 1979-03) between a sample color and a comparison color or between two colors. ⁇ E can be determined photometrically according to various industrial standards, usually by measurement according to the standards DIN5033 and
- ⁇ E is preferably determined according to standard DIN 5033 part 1 and DIN 6174, based on the L * a * b * color space, e.g.
- a colorimeter such as the Konica Minolta CR-300, CR-310, CR-311 (Konica Minolta Sensing, Inc., Osaka, Japan), preferably with the CR-300, and as described in the Konica Minolta CR 300, CR-310, CR-311 (Konica Minolta Sensing, Inc., Osaka, Japan), German version,
- ⁇ E values for perceptible color differences are usually between 2 and 5, with a very good result above 5, indicating a clear color difference (the presence of a different color) with the naked eye (http://de.wikipedia.org/ wiki / Delta E): ⁇ E rating
- hydrophilic and hydrophobic have the usual meaning in the chemical jargon.
- a “hydrophilic” dye is thus a dye which is preferably soluble in water or polar solvents. Hydrophilic dyes are typically polar compounds that are either ionic, have a dipole moment, and / or contain electronegative groups. In contrast, a “hydrophobic” dye dissolves preferentially in non-polar media and has no ionic functional groups and only weakly electronegative functional groups.
- the present invention relates to the use of hydrophobin in the non-permanent staining of keratin and keratin-containing materials, as well as corresponding hydrophobin-containing cosmetic compositions and kits.
- the color difference between hydrophobin-treated and untreated dyed hair expressed as ⁇ E and preferably determined according to DIN 5033 and / or calculated according to DIN 6174, eg according to the instructions in the Konica Minolta CR-300, CR-310, CR-311 (Konica Minolta Sensing, Inc., Osaka, Japan), German version, version number 527 349 / 9.99 (see Section "Definitions" and Ex. 6), can be more than 2, preferably more than 4, more preferably more than 5
- This effect of the hydrophobin may be due to the fact that the hydrophobin can increase the hydrophilicity of a keratin-containing surface, especially the surface of hair.
- compositions according to embodiments (2) and (3) and the use according to embodiment (4) preferably serve only for the cosmetic coloring of keratin and thus do not represent a therapeutic treatment of the human or animal body.
- the object of the present invention is the coloring of keratin.
- the keratin is present either as pure keratin or is part of keratin-containing materials.
- Preferred keratins or keratin-containing materials are skin, hair, nails, horns, wool, leather, fur, fur and feathers. Particularly preferred are keratinic fibers, especially hair and wool.
- the method according to embodiment (1) is used for coloring hair, especially hair of the main hair, and the compositions according to embodiments (2) and (3) and the use (4) for dyeing hair, especially hair of the head.
- the keratin dyed according to the invention may be of human or animal origin and is preferably of human origin.
- the method according to embodiment (1) and the use according to embodiment (4) of the present invention requires applying at least one hydrophobin to the keratin to be dyed.
- the at least one hydrophobin is preferably part of a composition which contains further cosmetically acceptable ingredients.
- hydrophobin or “hydrophobins” are preferably polypeptides of the general formula (I)
- X is for each of the 20 naturally occurring amino acids (Phe, Leu, Ser, Tyr, Cys, Trp, Pro, His, GIn, Arg, He Met, Thr, Asn, Lys, VaI, Ala, Asp, Glu, Gly) can stand.
- the radicals X may be the same or different. In this case, the indices standing at X each represent the number of amino acids in the respective subsequence X.
- indices n and m independently represent natural numbers. In general, neither m nor n are zero, but are usually 1 or more.
- m and n can be independently from 1 to 500. Preferably, m and n are independently from 15 to 300.
- the amino acids designated C * to C ° are preferably cysteines; but they can also be replaced by other amino acids of similar space filling, preferably by alanine, serine, threonine, methionine or glycine. However, at least four, preferably at least five, particularly preferably at least six, and in particular at least seven, of the positions C * to C ° should be occupied by cysteine.
- Cysteines at the positions C * to C ° may either be reduced in the proteins according to the invention or form disulfide bridges with one another.
- the intramolecular formation of CC bridges in particular the formation of at least one, preferably two, more preferably three and most preferably four intramolekularischen Disulf ⁇ dmaschinen.
- cysteines by amino acids of similar space filling, it is advantageous to replace those C-positions in pairs, which can form intramolecular disulfide bridges with one another in the presence of Cys at the positions concerned.
- positions indicated by X are also a cysteine, serine, alanine, glycine, methionine or threonine, the numbering of the individual C positions in the general hydrophobin formulas may change accordingly. Additional cysteines at X positions are also capable of forming disulfide bridges.
- the indices n and m stand for natural numbers including the number zero. In general, neither m nor n are zero, but are usually 1 or more. For example, m and n can be independently from 1 to 500.
- m and n are independently from 15 to 300.
- at least six of the radicals named C are cysteine, more preferably all of C is cysteine.
- Most preferably, at least a pair of these cysteines form a disulfide bridge, and the formation of more than one disulfide bridge, that is, 2, 3, or 4 of these bridges, is most preferred.
- Particular preference is given to hydrophobins of the general formula (III)
- the indices n and m are natural numbers from 1 to 200.
- at least six of the radicals named C are cysteine. Most preferably, all of the C radicals are cysteine. Most preferably, at least a pair of these cysteines form a disulfide bridge, and the formation of more than one disulfide bridge, that is, 2, 3, or 4 of these bridges, is most preferred.
- Peptide sequences that are naturally linked to the other components of the hydrophobin may be peptide sequences that are not naturally linked to the other components of the hydrophobin. These are also to be understood as meaning those groups X n and / or X m in which a peptide sequence occurring naturally in the protein is extended by a peptide sequence which does not occur naturally in the protein.
- the group X n and / or X m may contain, wholly or in part, peptide sequences which do not naturally occur in the hydrophobin protein.
- fusion partner The non-naturally occurring in the protein peptide sequences from which the group X n and / or m X can be partially or entirely consist shall be referred to hereinafter also as a fusion partner.
- These fusion partners are usually at least 20, preferably at least 35 amino acids long. They may, for example, be sequences from 20 to 500, preferably from 30 to 400 and particularly preferably from 35 to 100 amino acids.
- Suitable fusion partners have been disclosed, for example, in WO 2006/082251, WO 2006/082253, WO 2006/131564 and WO 2007/014897. These fusion partners are preferred fusion partners in the context of the present invention.
- the fusion partner can be selected from a variety of proteins.
- fusion partners Only a single fusion partner can be linked to the remainder of the polypeptide, or multiple fusion partners can be linked to the remainder of the polypeptide. For example, two fusion partners at one of the X n or X m positions may be linked to the rest of the polypeptide, or there may be one or more fusion partners at each of the two positions.
- Particularly suitable fusion partners are proteins which occur naturally in microorganisms, preferably in prokaryotes, in particular in Escherichia coli or Bacillus subtilis.
- particularly suitable fusion partners are the polypeptides having the sequences yaad (SEQ ID NO: 16 in WO 2006/082251, SEQ ID NO: 15 or 16 in WO 2007/014897), yaae (SEQ ID NO: 18 in WO
- fusion partners are yaad and truncated sequences derived therefrom, as described in the present description and in WO 2006/082251 and WO 2007/014897.
- yaad and yaad40 are also suitable.
- fragments or homologs of said sequences which comprise only one contiguous portion, for example from 70 to 99%, preferably from 5 to 50%, and more preferably from 10 to 40% of the amino acids of said sequences, or in which individual Amino acids, or nucleotides are exchanged with respect to the said sequence, wherein the percentages in each case refers to the total number of amino acids.
- the hydrophobin optionally in addition to one of the aforementioned fusion partners - as one of the groups X n or X m or as a terminal component of such a group still a so-called affinity domain (affinity tag / aff ⁇ nity tail) on.
- affinity domains include (His) k, (Arg) k, (Asp) k, (Phe) k or (Cys) k
- k is generally a natural number from 1 to 10. It is preferably a (His) k group, where k is one of the numbers four to six.
- the group X n and / or X m can consist exclusively of such an affinity domain or of naturally or not naturally linked to the rest of the polypeptide amino acids or polypeptides and such an affinity domain.
- the hydrophobin is additionally modified on its polypeptide sequence, for example by glycosylation, acetylation or else by chemical cross-linking, for example with glutaric dialdehyde.
- Hydrophobins their sequences and their preparation are disclosed, for example, in WO 2006/082251, the contents of which are hereby expressly incorporated into the present invention. Those described in WO2006 / 082251
- Hydrophobins are preferred for the practice of the present invention.
- hydrophobins for practicing the present invention are the hydrophobins of the dewA, rodA, hypA, hypB, sc3, basF, basf2 types, more particularly dewA hydrophobins (in the examples in the fusion proteins
- Hydrophobins of type dewA These hydrophobins and their sequences are disclosed, for example, in WO 2006/082251 and WO 2007/014897, the contents of which are hereby expressly incorporated into the present invention. Unless otherwise indicated, the sequence names given below and SEQ ID NOs refer to sequences disclosed in WO 2006/082251. An overview table with the SEQ ID numbers can be found in WO 2006/082251 on page 20.
- hydrophobins selected from the group consisting of yaad-Xa-dewA-his (SEQ ID NO: 20), yaad-Xa-rodA-his (SEQ ID NO: 22) and yaad-Xa-basfl-his (SEQ ID NO: 24) with the polypeptide sequences shown in parentheses and the coding therefor
- Nucleic acid sequences in particular the sequences according to SEQ ID NO: 19, 21, 23. Particularly preferred may yaad-Xa-dewA-his (SEQ ID NO: 20 in WO 2006/082251 or SEQ ID NO: 19 and 20 WO 2007/014897 ) are used. Also, proteins which, starting from the polypeptide sequences shown in SEQ ID NO: 20, 22 or 24, by exchange, insertion or deletion of at least one, preferably up to 5% of all amino acids, more preferably up to ten, most preferably to to give five amino acids, and which still possess at least 50% of the biological property of the starting proteins, are particularly preferred embodiments. The biological property of the proteins is understood here to mean the change in the contact angle described below and / or the effect on keratin described below.
- Hydrophobins particularly suitable for carrying out the present invention are further derived from yaad-Xa-dewA-his (SEQ ID NO: 20), yaad-Xa-rodA-his (SEQ ID NO: 22) or yaad-Xa-basfl-his ( SEQ ID NO: 24) hydrophobins derived by truncation of the yaad fusion partner.
- a shortened yaad residue can advantageously be used.
- the truncated residue should, however, comprise at least 20, preferably at least 35, contiguous amino acids of the yaad sequence.
- a truncated radical having 20 to 293, preferably 25 to 250, more preferably 35 to 150 and most preferably 35 to 100 amino acids can be used.
- a particularly suitable protein is yaad40-Xa-dewA-his (SEQ ID NO: 25 and 26 in WO 2007/014897), which has a reduced to 40 amino acids yaad residue.
- a cleavage site between the fusion partner or fusion partners and the remainder of the polypeptide can be used to cleave off the fusion partner (for example by BrCN cleavage on methionine, factor Xa, enterokinase,
- Thrombin, TEV cleavage, etc. is particularly preferred.
- an Xa site e.g. an interface of the hydrophobins used in the examples.
- hydrophobins are surface-active polypeptides. They can be isolated from natural sources, but can also be obtained by genetic engineering. In principle, both hydrophobins of one and the other origin are suitable for carrying out the present invention.
- hydrophobins used according to the invention can be prepared chemically by known methods of peptide synthesis, for example by solid phase synthesis according to Merrifield.
- Naturally occurring hydrophobins can be isolated from natural sources by suitable methods. As an example, let Wösten et. al., Eur. J Cell Bio. 63, 122-129 (1994) or WO 96/41882.
- hydrophobins from Talaromyces thermophilus which contain no fusion partner
- the preparation of hydrophobins containing a fusion partner can preferably be carried out by genetic engineering methods in which a nucleic acid sequence coding for the fusion partner and one for the remainder of the polypeptide, in particular DNA sequence, are combined so that in a host organism by gene expression of the combined Nucleic acid sequence, the desired protein is generated.
- a production method for example, is disclosed by WO 2006/082251 or WO 2006/082253.
- the fusion partners greatly facilitate the production of hydrophobins. Hydrophobins containing a fusion partner are produced in genetically engineered processes with significantly better yields than hydrophobins that do not contain a fusion partner.
- hydrophobins produced by the host organisms according to the genetic engineering process can be worked up in a manner which is known in principle and purified by means of known chromatographic methods. In general, isolated, in particular purified, hydrophobins are used to carry out the invention.
- the fermented cells are first separated from the Fermetationsbrühe, digested and the cell debris from the inclusion bodies
- inclusion bodies separately.
- the latter can be done advantageously by centrifuging.
- the inclusion bodies for example by acids, bases and / or detergents can be digested in a manner known in principle in order to liberate the hydrophobins.
- the inclusion bodies with the hydrophobins used according to the invention can generally be completely dissolved within about 1 h already using 0.1 M NaOH.
- the solutions obtained may, if appropriate after adjusting the desired pH, be used for carrying out this invention without further purification.
- the hydrophobins can also be isolated from the solutions as a solid. The isolation can preferably be carried out by means of spray granulation or spray drying, as described in WO 2006/082253, page 12.
- the products obtained by the simplified work-up and purification process comprise, in addition to residues of cell debris, usually about 80 to 90% by weight of proteins.
- the amount of hydrophobins is generally from 30 to 80% by weight with respect to the amount of all proteins.
- the isolated Hy drophobin- containing products can be stored as solids.
- hydrophobins can be used as such or after cleavage and separation of the fusion partner for carrying out this invention.
- a cleavage is advantageously carried out after the isolation of the inclusion bodies and their dissolution.
- a biological property of the hydrophobins is the change of surface properties when a surface, e.g. a glass surface coated with hydrophobin proteins.
- the change of the surface properties can be experimentally determined, for example, by the contact angle of a water drop before and after the
- Coating the surface with the proteins is measured and the difference between the two measurements is determined.
- contact angle measurements is known in principle to the person skilled in the art.
- the measurements are carried out at room temperature with a water drop of 5 ⁇ l and using glass slides as substrate.
- the exact experimental conditions for an example suitable method for measuring the contact angle are shown in Example 10 of WO 2006/136607.
- the hydrophobins used can increase the contact angle.
- the hydrophobins can reduce the contact angle by at least 20 °, preferably at least 25 °, particularly preferably at least 30 °; at least 40 °; at least 45 °; in particular at least 50 °, in each case compared with the contact angle of a water droplet of the same size with the uncoated glass surface.
- the present invention relates to the effect of hydrophobin on the binding of tinting dyes and semipermanent dyes to hair.
- the binding of hydrophobin to the skin and hair can be tested as described in Examples 1 to 4 (identical to Examples 11 to 14 of WO 2006/136607).
- compositions of the invention according to embodiments (2) and (3), and compositions for use (4) in the method of embodiment (1) preferably contain the hydrophobin in a concentration of 0.001 to 5% by weight, more preferably in an amount of 0.005 to 3% by weight %, very particularly preferably from 0.01 to 1% by weight of total hydrophobin, based on the total
- composition Most preferred is a hydrophobin concentration of up to 0.2% by weight, more preferably from 0.01 to 0.05% by weight, most preferably 0.025% by weight.
- the total hydrophobin is the total amount of hydrophobin molecules of one or more hydrophobin molecular species in the composition. These concentration ranges also indicate the preferred concentrations at which the hydrophobin is applied to the keratin or keratin-containing material in the method of embodiment (1).
- the said hydrophobin concentrations are either already present in the inventive compositions according to embodiments (2) and (3), or the compositions for use (4) in the process according to embodiment (1), or they are prepared by diluting a concentrate before use of the Composition obtained.
- the hydrophobin is preferably present in a composition which preferably also contains a cosmetically acceptable carrier medium. This composition may contain only one hydrophobin or else a combination of different hydrophobins, eg a composition comprising two or three hydrophobins.
- the non-permanent staining of keratin according to the present invention further requires the application of at least one non-permanent dye, more specifically a non-permanent keratin dye, to the keratin to be stained.
- the non-permanent dye is applied as a component of a composition (colorant) containing the dye.
- the composition according to embodiment (2) and the kit according to embodiment (3) also relate to such a colorant.
- This colorant contains either one or more non-permanent dyes, typically several non-permanent dyes, preferably from 2 to 20 or any natural integer, more preferably from 4 to 10 non-permanent dyes.
- Commercially available tints and non-permanent colorants typically contain more than three different non-permanent dyes to achieve a particular hue (see the colorants used in the examples).
- non-permanent dyes is expressly referred to the monograph Ch. Zviak, The Science of Hair Care, Chapter 7 (pages 248-250, direct dyes), published as volume 7 of the series 'Oematology' (eds .: Ch., Culnan and H.
- Non-permanent dyes mentioned in these works are non-permanent dyes suitable for practicing the present invention.
- Non-permanent dyes in the context of the present invention are preferably substantive dyes.
- As direct dyes all direct dyes commonly used in hair dyeing can be used.
- Such substantive dyes are usually nitrophenylenediamines, nitroaminophenols, azo dyes, anthraquinones, tri-phenylmethane dyes, indoanilines or indophenols.
- Preferred substantive dyes are those under the international designations or trade names HC Yellow 2, HC Yellow 4, HC Yellow 5, HC Yellow 6, HC Yellow 9, HC Yellow 12, HC Yellow 13, Acid Yellow 1, Acid Yellow 10, Acid Yellow 23, Acid Yellow 36, HC Orange 1, Disperse Orange 3, Acid Orange 7, HC Red 1, HC Red 3, HC Red 10, HC Red 11, HC Red 13, Acid Red 33, Acid Red 52, HC Red BN, Pigment Red 57: 1, HC Blue 2, HC Blue 12, Disperse Blue 3, Acid Blue 7, Acid Green 50, HC Violet 1, Disperse Violet 1, Disperse Violet 4, Acid Violet 43, Disperse Black 9, Acid Black 1, and Acid Black 52 known compounds as well as 1,4-diamino-2-nitrobenzene, 2-amino-4-nitrophenol, 1,4-bis ( ⁇ -hydroxyethyl) amino-2-nitrobenzene, 3-nitro-4- ( ⁇ -hydroxyethyl) aminophenol, 2- (2'-hydroxyethyl) amino-4,6-dinitrophenol, 1- (2'-hydroxyethy
- Preferred substantive dyes are also cationic substantive dyes. Particularly preferred are (a) cationic
- Triphenylmethane dyes such as Basic Blue 7, Basic Blue 26, Basic Violet 2 and Basic Violet 14, (b) aromatic systems substituted with a quaternary nitrogen group such as Basic Yellow 57, Basic Red 76, Basic Blue 99, Basic Brown 16 and Basic Brown 17, as well as (c) direct dyes containing a heterocycle containing at least one quaternary
- Nitrogen atom such as Basic Yellow 87, Basic Orange 31 and Basic Red 51.
- the cationic substantive dyes sold under the trademark Arianors® are, according to the invention, particularly preferred cationic substantive dyes.
- the at least one non-permanent dye in embodiments (1) to (4) of the present invention is selected from the group consisting of Basic Red 51, Basic Red 76, HC Red No. 10, HC Red No.11, Basic Violet 2, hydroxyethyl 2-nitro-p-toluidine, HC Blue No.2, HC Yellow No.9, HC Yellow No.13, HC Yellow No.2, 2-amino 6-chloro-4-nitrophenol, HC Blue No.12, N, N-bis (2-hydroxyethyl) -2-nitro-p-phenylenediamine, Basic Blue 99, 4-amino-3-nitrophenol, 4-hydroxypropylamino-3-nitrophenol , 3-nitro-p-hydroxyethylaminophenol, HC Blue No.11, Basic Brown 17, HC Red No.1, HC Red No.7, HC Red No.13, HC Orange No.l and HC Red No.3, in particular from Basic Violet 2 and hydroxyethyl 2-nitro-p-toluidine.
- a combination of several of the most preferred dyes in particular a selection (for example, those in Examples multiply used dyes) or all of the dyes mentioned in the examples.
- preparations according to the invention may also contain naturally occurring dyes such as those found in henna red, henna neutral, henna black, chamomile flower, sandalwood, black tea, buckthorn bark, sage, bluewood, madder root, catechu, seder and alkano root.
- naturally occurring dyes such as those found in henna red, henna neutral, henna black, chamomile flower, sandalwood, black tea, buckthorn bark, sage, bluewood, madder root, catechu, seder and alkano root.
- the non-permanent dye may be basically hydrophobic or hydrophilic.
- the non-permanent dye in the embodiments (1) to (4) is a hydrophilic dye.
- the hydrophobin improves its binding to the surface of the keratin because it can make the keratin surface more hydrophilic.
- hydrophobic dyes can penetrate a hydrophobin layer on the keratin surface and intercalate into the deeper layers. Such stabilized hydrophobic dyes remain longer on the hair. Their use as non-permanent dyes is therefore also an aspect of the present invention.
- the use of at least one hydrophilic dye in the colorant is preferred.
- the majority of non-permanent dyes present in the colorant are hydrophilic (greater than 50% by weight, based on the total colorants), most preferably all non-permanent dyes present in the colorant are hydrophilic.
- the colorants according to the invention or used according to the invention preferably contain the non-permanent dyes in a concentration of 0.001 to 20% by weight, more preferably in a concentration of 0.001 to 10% by weight, very particularly preferably of 0.1 to 5% by weight. based on the total colorant. It is not necessary for the non-permanent dyes to be the same as each other. Rather, in the hair colorants according to the invention, due to the production process for the individual dyes, in minor amounts, other components may be included, as far as they do not adversely affect the dyeing result or for other reasons, eg. As toxicological, must be excluded.
- compositions useful in the practice of the present invention may also contain one or more permanent dyes or their precursors. However, the use of compositions without such permanent dyes or their precursors is preferred.
- the nonpermanent dye is a component of a colorant, preferably a hair colorant, a skin colorant or a nail colorant, in particular for coloring human hair, skin or nails.
- the colorant is particularly preferably a hair colorant, very particularly preferably a hair colorant, a semi-permanent or a demipermanent hair colorant.
- the colorant is a tint or semipermanent hair dye, most preferably a semipermanent hair dye.
- the non-permanent dye is preferably applied to the keratin or keratin-containing material in process (1) as a component of such a composition.
- the colorant generally contains at least one cosmetically acceptable carrier medium and may additionally contain other ingredients customary in cosmetics.
- the colorant can - as it is often commercially available - ammonia or an ammonia salt such as NH 4 Cl included.
- an ammonia salt such as NH 4 Cl included.
- the presence of ammonia is not absolutely necessary.
- the inventive Compositions and the compositions used for the process according to embodiment (1) and the use according to embodiment (4) no ammonia or no ammonia salt.
- the hydrophobin and non-permanent dye may be applied to the keratin separately (in separate compositions) or as a combination in a single composition.
- the hydrophobin and the non-permanent dye are preferably applied separately from each other or in separate compositions.
- the hydrophobin and non-permanent dye may further be applied either simultaneously or sequentially to the keratin or keratin-containing material. Preferably, they are applied successively.
- process (1) may include one or more steps.
- process (1) comprises at least the following steps: (a) applying at least one hydrophobin of structural formula (I) to the keratin; and
- steps (b) and (b) are performed either simultaneously or sequentially.
- the hydrophobin or the non-permanent dye is preferably contained in a composition which contains further cosmetically acceptable ingredients.
- steps (a) and (b) are carried out simultaneously, only one composition is applied to the hair, which then contains both the hydrophobin and the non-permanent dye.
- This composition can be prepared by mixing two separate compositions, one containing the hydrophobin and the other the non-permanent dye.
- the hydrophobin preferably in the form of a hydrophobin-containing composition, is first applied to the hair. This composition acts on the keratin for a certain exposure time. Thereafter, a composition is applied to the hair containing at least one non-permanent dye.
- the application of the last-mentioned composition can be directly followed by the action time of the hydrophobin-containing composition, or further steps (ie one or more steps) for the treatment of keratin are carried out between steps (a) and (b).
- these further steps may be any measures for the cosmetic treatment of the hair as long as they neither remove the hydrophobin layer nor affect the final result of the dyeing.
- these further steps are selected from the group consisting of: one or more washings of the keratin, one or more times drying of the keratin at
- Such a further step of process (1) is particularly preferably the drying of the keratin or keratin-containing material after application of the
- the keratin is dried between steps (a) and (b).
- the keratin to terminate the contact time of the hydrophobin-containing composition by applying warm air, for example air at a temperature of> 30 0 C, preferably from 50 0 C ⁇ 5 0 C, by means of a hot air source (such as Hair dryer or other hot air source that can generate temperatures such as a hair dryer) or dried at room temperature.
- a hot air source such as Hair dryer or other hot air source that can generate temperatures such as a hair dryer
- the keratin is dried immediately after the exposure time of the hydrophobin by a hair dryer, as in Example 5, variant (b) is the case before the dye is applied to the hair.
- Dye is removed in a further preferred aspect of the method (1) not bound to the keratin part of the applied hydrophobin from the keratin to be dyed, in particular by washing. More preferably, the remainder of the applied hydrophobin-containing composition is washed out to complete its exposure time and / or after the above-described drying of the keratin at the end of the exposure time before step (b) is performed.
- the keratin is most preferably dried after washing, but preferably not heated (ie, dried at room temperature, for example), and only then is the composition containing the dye applied to the keratin.
- the keratin is dried immediately following the exposure time of the hydrophobin before the next steps are performed.
- the drying is carried out by applying warm air, for example air at a temperature of> 30 0 C, preferably from 50 0 C ⁇ 5 0 C, by means of a hot air source, preferably with a hair dryer.
- the time interval between the end of step (a) and the beginning of step (b) should not be increased unnecessarily in a sequential execution ((b) after (a)) by this further step or these further steps. It is preferably at most 2 hours, more preferably from 2 to 70 minutes, most preferably from 4 to 30 minutes, and most preferably from 5 to 15 minutes.
- the exposure time of the hydrophobin-containing composition may be up to 2 hours. It is preferably from 2 to 90 minutes, for example from 3 to 70 minutes, from 4 to 30 minutes, or from 5 to 15 minutes.
- step (b) is preferably carried out with a commercial colorant according to the manufacturer, but can also be carried out with other compositions containing a non-permanent dye.
- the keratin can be washed and dried.
- the steps of the method (1) can also be repeated several times.
- Example 5 The sequence and nature of the individual steps in Example 5 is a preferred way of carrying out the process (1) according to the invention. From these steps, a selection can be made, as far as it meets the above requirements.
- Both the non-permanent dye and the hydrophobin are preferably contained (separately or as a combination) in a composition.
- the compositions according to the invention are preferably cosmetic
- compositions In addition to hydrophobin and / or non-permanent dye, they generally contain a cosmetically acceptable medium and suitable further ingredients which support the cosmetic effect, in particular auxiliaries and additives customary in hair treatment compositions. These ingredients should not adversely affect the staining result.
- suitable further ingredients which support the cosmetic effect, in particular auxiliaries and additives customary in hair treatment compositions. These ingredients should not adversely affect the staining result.
- Such basic formulations for cosmetic compositions and the ingredients suitable therefor are well known to the person skilled in the art and can be found in cosmetics manuals, such as, for example, in Schrader, bases and formulations of cosmetics, Wegig Verlag, Heidelberg, 1989, or Umbach, cosmetics: development, production and application of cosmetic products, 2nd extended edition, 1995, Georg Thieme Verlag.
- compositions of the invention are i.a. as cosmetic preparations, for example as creams, emulsions, gels or surfactant-containing foaming solutions, e.g. Shampoos, foam aerosols or other preparations suitable for use on the hair.
- Usual constituents of such aqueous cosmetic preparations are, for.
- As wetting and emulsifying agents such as anionic, nonionic and ampholytic surfactants, eg.
- anionic, nonionic and ampholytic surfactants eg.
- fatty alcohol sulfates, alkanesulfonates, ⁇ -olefinsulfonates, Fettalkoholpolyglykolethersulfate, Ethylenoxidenvironrungs eg.
- fatty alcohol sulfates, alkanesulfonates, ⁇ -olefinsulfonates, Fettalkoholpolyglykolethersulfate, Ethylenoxidenvironrungs eg.
- fatty alcohol sulfates, alkanesulfonates, ⁇ -olefinsulfonates, Fettalkoholpolyglykolethersulfate, Ethylenoxidenvironrungs eg.
- methyl or hydroxyethyl cellulose starch, fatty alcohols, paraffin oils, fatty acids, perfume oils and hair care additives such.
- water-soluble cationic ampholytic and anionic polymers protein derivatives, pantothenic acid, cholesterol, dyes, drugs such as panthenol, allantoin, Pyrrolidoncarbonklaren and their salts, plant extracts and vitamins, light stabilizers, bodying agents such as sugar esters, polyol esters or Polyolalkylether, waxes such as beeswax and montan wax, complexing agents such as EDTA, NTA and phosphonic acids, swelling and penetrating agents such as glycerol, propylene glycol monoethyl ether, carbonates, bicarbonates, guanidines, ureas and primary, secondary and tertiary phosphates, pearlescing agents such as ethylene glycol mono- and distearate, propellants such as propane-butane mixtures, N
- the erf ⁇ ndungswashen compositions can, irrespective of the type of cosmetic preparation z.
- B. as a cream, gel or shampoo have a weakly acidic, neutral or alkaline pH. Preference is given to a pH range from 6 to 8. The adjustment of the pH is carried out with the aid of customary pH adjusters, but preferably not with ammonia or other chemicals considered harmful.
- compositions according to the invention in addition to either hydrophobin or non-permanent dye or in addition to a combination of the two said ingredients, additionally contain at least one cosmetically active ingredient, the uptake and / or effect of which is improved by the presence of hydrophobin, or this is cosmetically active Ingredient is applied separately (in pure form or as part of a composition).
- the additional cosmetically active ingredient is preferably hydrophilic.
- effector molecules Preferred cosmetically active ingredients whose uptake is improved by hydrophobin are described in WO 2006/136607 as "effector molecules", to the corresponding passages of which reference is expressly made.
- effector molecules can be used as cosmetically active ingredients in the compositions according to the invention.
- effector molecule refers to molecules which have a certain, predictable effect. These may be either proteinaceous molecules, such as enzymes, or else non-proteinogenic molecules, such as dyes, light stabilizers, vitamins and fatty acids, sugars or metal ion-containing compounds.
- sugars are glucans and especially sugars of natural origin, such as e.g. from honey or grain, preferred.
- enzymes peptides and antibodies are preferred.
- oxidases peroxidases, proteases, tyrosinases, metal-binding enzymes, lactoperoxidase, lysozyme, amyloglycosidase, glucose oxidase, superoxide dismutase, photolyase, calalase.
- Hydroxylates of proteins from plant and animal sources for example hydro lysates of proteins of marine origin, milk or silk hydrolysates, are also very suitable as proteinaceous effector molecules.
- peptides used for anti-aging such as Matrixyl (INCI name glycerol-water-butylene glycol-carbomer-polysorbate 20-palmitoyl pentapeptide-4), Argireline (INCI name Aqua, acetyl-hexapeptide-3) , Rigin (INCI Name Water (and) Glycerin (and) Steareth-20 (and) Palmitoyl tetrapeptide-7), Eyeliss (INCI Name Water-Glycerol-Hespiridine Methyl Chalcone-Steareth-20-Dipeptide-2-Palmitoyl Tetrapeptide-7) Regu-Age (INCI Name Oxido Reductases-Soy Peptides-Hydrolyzed Rice Bran Extract) and Melanostatin 5 (INCI name aqua-dextran-nonapetide-1).
- Matrixyl INCI name glycerol-water-butylene glycol-car
- non-proteinaceous effector molecules are non-protein anti-aging agents, e.g. Caffeine, and antioxidants are preferred as effector molecules.
- Antioxidants also referred to as radical scavengers, are capable of neutralizing so-called free radicals. These are aggressive compounds that are physiologically involved in numerous metabolic processes and the
- Antioxidants include carotenoids, ascorbic acid (vitamin C, E 300) as well as sodium L-ascorbate (E 301) and calcium L-ascorbate (E 302); Ascorbyl palmitate (E 304); Butylhydroxyanisole (E 320); Butylhydroxytoluene (E 321); Calcium disodium EDTA (E 385); Gallate as well as propyl gallate (E 310), octyl gallate (E 311) and dodecyl gallate (lauryl gallate) (E 312); Isoascorbic acid (E 315) as well as sodium isoascorbate (E 316); Lecithin (E 322); Lactic acid (E 270); Multiple-
- Phosphates such as diphosphates (E 450), triphosphates (E 451) and polyphosphates (E 452); Sulfur dioxide (E 220) as well as sodium sulphite (E 221), sodium bisulphite (E 222), sodium disulphite (E 223), potassium sulphite (E 224), calcium sulphate (E 226), calcium bisulphite (E 227) and potassium bisulphite (E 228); Selenium; Tocopherol (vitamin E, E 306) as well as alpha-tocopherol (E 307), gamma-tocopherol (E.
- At least one compound from the above-mentioned group of antioxidants is selected as the antioxidant.
- carotinoids are to be understood as meaning the following compounds: beta-carotene, lycopene, lutein, astaxanthin, zeaxanthin, cryptoxanthin, citranaxanthin, canthaxanthin, bixin, beta-apo-4-carotenal, beta-apo-8-carotenal, beta-apo -8-carotenoic acid ester, singly or as a mixture.
- carotenoids are beta-carotene, lycopene, lutein, astaxanthin, zeaxanthin, citranaxanthin and canthaxanthin.
- retinoids in the context of the present invention is meant vitamin A alcohol (retinol) and its derivatives such as vitamin A aldehyde (retinal), vitamin A acid (retinoic acid) and vitamin A esters (e.g., retinyl acetate, retinyl propionate and retinyl palmitate).
- retinoic acid encompasses both all-trans retinoic acid and 13-eis retinoic acid.
- the terms retinol and retinal preferably include the all-trans compounds.
- the preferred retinoid used is all-trans retinol, referred to below as retinol.
- effector molecules are vitamins, especially vitamin A, and their esters.
- Vitamins are essential organic compounds which are either not synthesized in the animal and human organism or only in insufficient quantities. Based on this definition, 13 components or groups of components have been classified as vitamins.
- the fat-soluble vitamins include vitamin A (retinol), vitamin D (calciferols), vitamin E (tocopherols, tocotrienols) and vitamin K (phylloquinone).
- the water-soluble vitamins include vitamin B1 (thiamine), vitamin B2 (riboflavin), vitamin B6 (pyridoxal group), vitamin B12 (cobalamins), vitamin C (L-ascorbic acid), pantothenic acid, biotin, folic acid and niacin.
- Vitamins, provitamins and vitamin precursors from groups A, C, E and F in particular 3,4-didehydroretinol, beta-carotene (provitamin of vitamin A), ascorbic acid (vitamin C), and the palmitic acid esters, glucosides or phosphates of ascorbic acid, tocopherols , in particular a-tocopherol and its esters, eg the acetate, nicotinate, phosphate and succinate; vitamin F, which is understood as meaning essential fatty acids, especially linoleic acid, linolenic acid and arachidonic acid.
- Vitamin E is a collective term for a group of (to date) eight fat-soluble substances with antioxidant and non-antioxidant effects. Vitamin E is part of all membranes of animal cells, but is formed only by photosynthetically active organisms such as plants and cyanobacteria.
- Four of the eight known Vita-min E forms are called tocopherols (alpha-tocopherol, beta-tocopherol, gamma-tocopherol and delta-tocopherol).
- the other four forms of vitamin E heretofore known are tocotrienols (alpha tocotrienol, beta tocotrienol, gamma tocotrienol and delta tocotrienol).
- derivatives of these substances such as alpha-tocopheryl acetate may also be advantageous.
- Vitamin A and its derivatives and provitamins advantageously show a particular skin-smoothing effect.
- vitamins, provitamins or vitamin D precursors of the vitamin B group or derivatives thereof which are preferably to be used according to the invention and the derivatives of 2-furanone include, inter alia: Vitamin Bl, common name thiamine, chemical name 3 - [(4'-amino-2'-methyl-5'-pyrimidinyl) methyl] -5- (2-hydroxyethyl) -4-methylthiazolium chloride.
- Vitamin B2 common name riboflavin, chemical name 7,8-dimethyl-10- (l-D-ribityl) benzo [g] pteridine-2,4 (3H, 10H) -dione.
- riboflavin z. B. in Mol-ke other riboflavin derivatives can be isolated from bacteria and yeasts.
- a stereoisomer of riboflavin which is likewise suitable according to the invention is the lyxoflavin which can be isolated from fishmeal or liver and carries a D-arabityl residue instead of the D-ribityl.
- Vitamin B3 the compounds nicotinic acid and nicotinamide (niacinamide) are often performed.
- Preferred according to the invention is the nicotinic acid amide.
- Vitamin B5 pantothenic acid and panthenol
- Panthenol is preferably used.
- Suitable derivatives of panthenol according to the invention are, in particular, the esters and ethers of panthenol and also cationically derivatized panthenols.
- Particularly preferred derivatives are the substances which are also commercially available
- Vitamin B6 which is understood hereunder no uniform substance, but the known under the common names pyridoxine, pyridoxamine and pyridoxal derivatives of 5-hydroxymethyl-2-methylpyridin-3-ols.
- Vitamin B7 also known as vitamin H or "skin vitamin”.
- Biotin is (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] imidazole-4-valeric acid.
- vitamins salts, esters, sugars, nucleotides, nucleosides, peptides and lipids
- suitable derivatives of vitamins salts, esters, sugars, nucleotides, nucleosides, peptides and lipids
- nucleic acids such as DNA and RNA may be suitable effector molecules, e.g. as a moisturizer.
- Preferred lipophilic, oil-soluble antioxidants from this group are tocopherol and its derivatives, gallic acid esters, flavonoids and carotenoids, and butylhydroxytoluene / anisole.
- As water-soluble antioxidants are amino acids, eg. As tyrosine and cysteine and their derivatives and tanning agents, especially those of plant origin are preferred.
- Triterpenes in particular triterpenic acids such as ursolic acid, rosmarinic acid, betulinic acid, boswellic acid and bryonic acid.
- Further preferred effector molecules are, preferably low-dose, fruit acids (alpha hydroxy acids) such as malic acid, citric acid, lactic acid, tartaric acid, glycolic acid. These may be present in concentrations of 0.1% to 35%, preferably 0.1% to 10%, in particular 1% to 10%, 1% to 5%, based on the total weight of the composition. Further preferred effector molecules are urea and derivatives thereof, as they can care for the scalp. These may be present in concentrations of 0.1% to 25%, preferably 0.1% to 10%, in particular 1% to 10%, 1% to 5%, based on the total weight of the composition. Urea and its derivatives are not to be equated with ammonia, which is preferably not used in the compositions and methods of the invention.
- UV light protection filters in particular the UV filters mentioned in WO 2006/136607.
- Such further cosmetically active ingredients are keratin-care substances and skin-care substances, in particular water-soluble vitamins, antioxidants, UV filters, glucans, flavonoids, and caffeine.
- vitamin C niacin (nicotinic acid, vitamin B3), pantothenic acid and panthenol (vitamin B5), vitamin B6, biotin (vitamin B7, vitamin H), vitamin B9 (folic acid) and vitamin B 12 or their derivatives.
- Panthenol, pantolactone, nicotinic acid amide, sodium ascorbyl phosphate and biotin are very particularly preferred according to the invention.
- UV filters water-soluble UV filters are preferred, Uvinul MS 40, Uvinul P 25, Uvinul DS 49 and Z-COTE are particularly preferred, and Uvinul MS 40 and P 25 are very particularly preferred.
- Uvinul MS 40 and P 25 are very particularly preferred.
- antioxidants flavonoids phenolic acids and polyphenols are preferred.
- cosmetically active ingredients selected from the group consisting of panthenol, ascorbic acid and its derivatives, water-soluble UV filters, caffeine.
- Aqueous extracts of fruits and herbs may also be part of the compositions of the invention.
- a specific embodiment of the present invention is the kit (3).
- Kit comprises two separate cosmetic compositions, namely
- the simultaneous application or application in the order (i) - (u) of the two compositions (i) and (ii) causes an increase in the color intensity and / or color stability of the dyeing compared to the sole use of the composition (ii).
- composition (ii) is preferably a conventional colorant for tinting, semi- or demipermanent coloring of hair.
- composition (i) or (ii) or both compositions in the kit additionally contain at least one cosmetically active ingredient, the uptake and / or effect of which is improved by the presence of hydrophobin.
- the kit may also comprise a further composition (iii) containing such a cosmetically active ingredient.
- hydrophobin is used to enhance the effect of nonpermanent dyeing of keratin or keratin containing material.
- the hydrophobin used is defined as described above for the other embodiments.
- the non-permanent dye used is as defined above.
- hydrophobins used in the examples were prepared according to the examples of Part A of WO 2007/014897.
- the sequence of the "hydrophobin A” used in the examples is given in WO 2007/014897 under SEQ ID NO: 19 and 20.
- This "hydrophobin A” is the hydrophobin dewA, which was fused with the protein yaad.
- the construct also contains an Xa interface and a tag (yaad-Xa-dewA-his).
- hydrophobin B used in the examples is given in WO 2007/014897 under SEQ ID NO: 25 and 26.
- This "hydrophobin B” is the hydrophobin dewA fused with the truncated yaad protein.
- the construct also contains an Xa-interface and a His-tag (yaad40-Xa-dewA-his).
- TBS 2OmM Tris; 15 mM NaCl pH 7.5
- TTBS TBS + 0.05% Tween20
- the first step is the transfer of the outer keratin layer from the skin to a stable carrier.
- a transparent adhesive strip was firmly applied to depilated human skin and removed again.
- the test can be performed directly on the transparent adhesive strip or through the adhering keratin layer re-gluing be transferred to a glass slide.
- the binding was detected as follows: transfer to incubation with the different reagents
- Washed 1x 5 min with TBS incubation with the hydrophobin to be tested (coupled to tag - e.g.
- a blue color precipitate indicates that hydrophobin has bound to the skin.
- the binding to nails can be determined analogously by incubating the hydrophobins to be investigated directly with the nail surface and measuring them accordingly.
- the binding to mucous membrane can be measured by measuring mucous membrane (for example, human oral mucosa) by means of a
- a quantitative assay was developed (Fig. 2 in WO 2006/136607).
- hair was first incubated with hydrophobin and washed off excess hydrophobin.
- an antibody-peroxidase conjugate was coupled via the His-tag of the hydrophobin. Unbound antibody-peroxidase conjugate was rinsed off again.
- the bound antibody-peroxidase conjugate [Monoclonal Antipoly-Histidine Peroxidase Conjugate, produced in mouse, lyophilized powder, Sigma Company] can convert a colorless substrate (TMB) into a colored product that is photometrically measured at 405 nm.
- the amount of absorption indicates the amount of bound hydrophobin or control protein.
- YaaD from B.subtilis was chosen as the comparison protein and likewise had a His tag for detection, as is necessary for this test.
- His tag instead of the His tag, other specific antibodies conjugated to peroxidase may also be used.
- BSA bovine serum albumin
- PBS phosphate buffered saline
- Tween 20 polyoxyethylene sorbitan monolaureate, n about 20
- hydrophobin-based binding test on hair showed a clear superiority of the binding of hydrophobin to hair compared to a substantially poorer binding of the control protein YaaD:
- Table 1 Quantitative Hydrophobin Activity Test Hair: 1) Buffer; 2) comparative protein yaad; 3) hydrophobin. The table shows the measured absorbance values at 405 nm.
- Example 4 Derivatization of hydrophobin with dye "Alexa" and binding to hair
- a coupling of dyes to hydrophobins can take place via the SH groups of the cysteines. Before coupling the dye Alexa Fluor 532, the disulfide bridges of the hydrophobin are split:
- the coupling of the dye is carried out according to the manufacturer's instructions (Alexa 532 Protein Labeling Kit, Molecular Probes, MP-A-10236).
- the coating of human hair with Alexa-coupled hydrophobin is performed as follows: Incubate 10 mg human hair with 50 ⁇ g / ml Alexa-hydrophobin or control protein yaad or uncoupled dye Alexa 532 in buffer TBS for 24 hours at room temperature. Wash twice with TBS / 0.05% Tween 20 - Wash Ix with TBS
- Example 5 Improved uptake and binding of the dyes of semi-permanent hair dyes by hydrophobin-treated hair
- step 2 Commercially available preparations (step 2) for semi-permanent hair dyeing were tested, namely
- HC Blue No.2 HC Yellow No.13, HC Yellow No.2, hydroxyethyl 2-nitro-p-toluidine, 2-amino-6-chloro-4-nitrophenol, HC Blue No.12, N, N Bis (2-hydroxyethyl) -2-nitro-p-phenylenediamine, Basic Blue 99, 4-amino-3-nitrophenol, 4-hydroxypropylamino-3-nitrophenol, 3-nitro-p-hydroxyethylaminophenol, HC Blue No.11, Basic Brown 17, HC Red No.1, HC Red No.7, HC Red No.13, HC Orange No. 1, Basic Violet No.2, HC Red No.3. The tests were carried out as follows:
- the hair was evaluated in comparison to hair treated with the control solution without hydrophobin. Particularly in the case of test variant (b), it was possible to detect a stronger color intensity in the hair treated with hydrophobin A and B, which is indicative of enhanced color binding and dye uptake compared to hair treated with reference solution. The dyestuff remained longer in the hair even after repeated washing out than without hydrophobin treatment.
- test variant (a) it was also evident that the dyestuff was retained longer in the hair when washed several times than without hydrophobin.
- the color intensity was also increased in test variant (a) compared to the comparison solution-treated hair.
- the hydrophobin B (SEQ ID NO: 26 in WO 2007/014897) treated and untreated hair were tinted with L'Oreal Si-Naturelle Foam Tint No. 01 (composition: Aqua, laureth-12, behentrimonium chloride, dimethyl ether, cetearyl alcohol , isobutane, glycol distearate, amodimethicone, butane, propane, HC red no.3, hydroxyethyl cellulose, hydroxyanthraquinone aminopropyl methyl morpholinium, methyosulfate, HC blue no.2, sodium lauryl sulfate, basic red 51, basic blue 99, trideceth-12, methylparaben, HC yellow no.9, cetrimonium chloride, butylparaben, ethylparaben, isobutylparaben, propylparaben, perfume).
- Minolta CR-300 and Process Unit Minolta DP-301 Konica Minolta Sensing, Inc., Osaka, Japan
- Minolta DP-301 Konica Minolta Sensing, Inc., Osaka, Japan
- ⁇ E is a measure of the color difference (synonym: color difference) between a sample color and a comparative color, measured and calculated according to CIE 1976,
- ⁇ E values were determined fully automatically according to the manufacturer's instructions by the photometer CR-300 according to the Chroma-Meter CR-300 / CR-310 / CR-331, Minolta, German version, version number: 527 349 / 9.99.
- the ⁇ E values are usually between 2 and 5 for noticeable color differences, with a very good result above 5, which indicates a clear color difference (the presence of a different color) with the naked eye (http://en.wikipedia.org/ wiki / Delta_E):
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09781840A EP2344117A2 (fr) | 2008-08-18 | 2009-08-14 | Utilisation d'hydrophobine dans la coloration non permanente de la kératine |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08162556 | 2008-08-18 | ||
EP09781840A EP2344117A2 (fr) | 2008-08-18 | 2009-08-14 | Utilisation d'hydrophobine dans la coloration non permanente de la kératine |
PCT/EP2009/060537 WO2010020587A2 (fr) | 2008-08-18 | 2009-08-14 | Utilisation d'hydrophobine dans la coloration non permanente de la kératine |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2344117A2 true EP2344117A2 (fr) | 2011-07-20 |
Family
ID=41346596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09781840A Withdrawn EP2344117A2 (fr) | 2008-08-18 | 2009-08-14 | Utilisation d'hydrophobine dans la coloration non permanente de la kératine |
Country Status (6)
Country | Link |
---|---|
US (1) | US20110192416A1 (fr) |
EP (1) | EP2344117A2 (fr) |
JP (1) | JP2012500241A (fr) |
CN (1) | CN102186455A (fr) |
CA (1) | CA2733760A1 (fr) |
WO (1) | WO2010020587A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010539125A (ja) * | 2007-09-13 | 2010-12-16 | ビーエーエスエフ ソシエタス・ヨーロピア | 浸透増強剤としてのハイドロフォビンポリペプチドの使用 |
CN102341464A (zh) * | 2009-03-09 | 2012-02-01 | 巴斯夫欧洲公司 | 水溶性聚合物和疏水蛋白的混合物在增稠水相中的用途 |
EP2605742A1 (fr) * | 2010-08-20 | 2013-06-26 | Unilever PLC | Composition de traitement capillaire |
CN105581917B (zh) * | 2016-02-23 | 2016-08-24 | 广州市高姿化妆品有限公司 | 增加角蛋白纤维,特别是毛发的抗拉强度和延伸性的化妆品组合物 |
CN112336643B (zh) * | 2020-10-10 | 2022-07-19 | 中芯生物科技(浙江)有限公司 | 蚕丝蛋白作为染发剂染料的载体的应用及毛发染色方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10019404A1 (de) * | 2000-04-19 | 2001-10-25 | Henkel Kgaa | Haarfärbeverfahren |
FR2833490B1 (fr) * | 2001-12-14 | 2004-12-10 | Oreal | Utilisition cosmetique d'au moins une hydrophobine pour le traitement des matieres keratiniques et compositions mises en oeuvre |
EP1891261A2 (fr) * | 2005-06-06 | 2008-02-27 | Basf Aktiengesellschaft | Procede d'enduction de surfaces de substrats fibreux |
DE102005029704A1 (de) * | 2005-06-24 | 2007-01-11 | Basf Ag | Verwendung von Hydrophobin-Polypeptiden sowie Konjugaten aus Hydrophobin-Polypeptiden mit Wirk-oder Effektstoffen und ihre Herstellung sowie deren Einsatz in der Kosmetik |
JP2010539125A (ja) * | 2007-09-13 | 2010-12-16 | ビーエーエスエフ ソシエタス・ヨーロピア | 浸透増強剤としてのハイドロフォビンポリペプチドの使用 |
-
2009
- 2009-08-14 JP JP2011523397A patent/JP2012500241A/ja not_active Withdrawn
- 2009-08-14 CN CN2009801408693A patent/CN102186455A/zh active Pending
- 2009-08-14 WO PCT/EP2009/060537 patent/WO2010020587A2/fr active Application Filing
- 2009-08-14 EP EP09781840A patent/EP2344117A2/fr not_active Withdrawn
- 2009-08-14 CA CA2733760A patent/CA2733760A1/fr not_active Abandoned
-
2011
- 2011-02-14 US US13/026,323 patent/US20110192416A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
See references of WO2010020587A3 * |
Also Published As
Publication number | Publication date |
---|---|
WO2010020587A2 (fr) | 2010-02-25 |
JP2012500241A (ja) | 2012-01-05 |
CN102186455A (zh) | 2011-09-14 |
CA2733760A1 (fr) | 2010-02-25 |
WO2010020587A3 (fr) | 2011-04-21 |
US20110192416A1 (en) | 2011-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7749286B2 (en) | Composition for dyeing keratin fibers and a method of dyeing hair using same | |
EP0835093B1 (fr) | Agents de coloration capillaires comportant au moins un principe actif traitant | |
US7550014B2 (en) | Composition for dyeing keratin fibers and a method of dyeing hair using same | |
KR101621032B1 (ko) | 염료로서 차 폴리페놀 및/또는 차 색소의 용도 및 그의 제품 | |
Boonsong et al. | Natural pigments from six species of Thai plants extracted by water for hair dyeing product application | |
KR101840743B1 (ko) | 모발 염색 제품 | |
US20100313362A1 (en) | Henna and vegetable dye based compositions for coloring of human hair | |
WO2007000214A1 (fr) | Produit destine au traitement des cheveux ou de la peau, qui contient un extrait de plantes appartenant a la famille des oleacees | |
EP2344117A2 (fr) | Utilisation d'hydrophobine dans la coloration non permanente de la kératine | |
KR20220137036A (ko) | 수성 라벤더 추출물을 수득하는 방법, 이러한 추출물을 포함하는 조성물 및 이들의 화장품 용도 | |
JP2008290977A (ja) | 毛髪保護組成物、毛髪化粧料、及び毛髪の保護方法 | |
ES2612261T3 (es) | Uso de una composición que comprende un hidrolizado peptídico de arroz no fermentado para estimular el crecimiento de los cabellos | |
KR101830860B1 (ko) | 닥나무 추출물을 함유하는 항노화용 화장료 조성물 | |
KR20090089032A (ko) | 산화형 염모제 조성물 | |
EP1800652B1 (fr) | Composition capillaire tinctoriale à base de colorants végétaux | |
KR20100014185A (ko) | 리포크로만-6 및 롱고자 추출물의 조합물을 포함하는 미용 조성물 및 이의 용도 | |
EP2198847A2 (fr) | Compositions comportant des agents auto-bronzants et des extraits de plantes | |
KR102707775B1 (ko) | 피부 외용제 조성물 | |
KR20130143296A (ko) | 치자황색소와 구주소나무잎 오일을 함유한 염모제 조성물 | |
KR102707776B1 (ko) | 피부 외용제 조성물 | |
KR102334971B1 (ko) | 밀배아 추출물을 포함하는 두피 및 모발 케어용 화장료 조성물 | |
EP2198848A2 (fr) | Compositions comportant des agents auto-bronzants et des sucres aminés | |
KR102098660B1 (ko) | 옻나무 추출물 또는 헛개나무 가지 추출물을 포함하는 모발 천연염색제 조성물 | |
RU2640907C1 (ru) | Оттеночная краска для волос на гелевой основе | |
KR20230173287A (ko) | 루시놀 및 천연 추출물을 함유하는 피부 미백용 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA RS |
|
17P | Request for examination filed |
Effective date: 20111021 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20130124 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20130525 |